Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	json	split
Tetrandrine ( TET) and fangchinoline ( FAN) are two naturally occurring analogues with a bisbenzylisoquinoline structure.	Tetrandrine,0,11,Chemical/Drug	TET,14,17,Chemical/Drug	fangchinoline,23,36,Chemical/Drug	FAN,39,42,Chemical/Drug	bisbenzylisoquinoline,89,110,Chemical/Drug	"[{""token"": ""Tetrandrine"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""TET"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""fangchinoline"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""FAN"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""bisbenzylisoquinoline"", ""start_span"": 89, ""end_span"": 110, ""type"": ""Chemical/Drug""}]"	train
There was a close parallel between the effect of vitamin D dose on artery calcification and the effect of vitamin D dose on the elevation of serum calcium, which suggests that vitamin D may induce artery calcification through its effect on serum calcium.	vitamin D,49,58,Chemical/Drug	vitamin D,106,115,Chemical/Drug	calcium,147,154,Chemical/Drug	vitamin D,176,185,Chemical/Drug	calcium,246,253,Chemical/Drug	"[{""token"": ""vitamin D"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin D"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin D"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Chemical/Drug""}]"	train
Dopamine turnover ratios ( DOPAC: DA and HVA: DA) were found to be lower in those animals exposed to the exploratory box when compared to their home cage counterparts.	Dopamine,0,8,Chemical/Drug	DOPAC,27,32,Chemical/Drug	DA,34,36,Chemical/Drug	HVA,41,44,Chemical/Drug	DA,46,48,Chemical/Drug	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""DOPAC"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 34, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""HVA"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Chemical/Drug""}]"	train
Changes of sodium and ATP affinities of the cardiac ( Na, K) - ATPase during and after nitric oxide deficient hypertension.	sodium,11,17,Chemical/Drug	ATP,22,25,Chemical/Drug	Na,54,56,Chemical/Drug	K,58,59,Chemical/Drug	nitric oxide,87,99,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 58, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""nitric oxide"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Chemical/Drug""}]"	train
During activation with Na +, the Vmax remained unchanged, however the K ( Na) increased by 50%, indicating a profound decrease in the affinity of the Na + - binding site in NO - deficient rats.	Na,23,25,Chemical/Drug	K,70,71,Chemical/Drug	Na,74,76,Chemical/Drug	Na,150,152,Chemical/Drug	NO,173,175,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 23, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 70, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 74, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 150, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 173, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	train
Inhibition of NO - synthase induced a reversible hypertension accompanied by depressed Na + - extrusion from cardiac cells as a consequence of deteriorated Na + - binding properties of the ( Na, K) - ATPase.	NO,14,16,Chemical/Drug	Na,87,89,Chemical/Drug	Na,156,158,Chemical/Drug	Na,191,193,Chemical/Drug	K,195,196,Chemical/Drug	"[{""token"": ""NO"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 87, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 191, ""end_span"": 193, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 195, ""end_span"": 196, ""type"": ""Chemical/Drug""}]"	train
Results presented here show that the differential sensitivities of BS and BR lines to beta - CCM can be extended to diazepam, picrotoxin, and pentylenetetrazol, suggesting a genetic selection of a general sensitivity and resistance to several ligands of the GABA ( A) receptor.	beta - CCM,86,96,Chemical/Drug	diazepam,116,124,Chemical/Drug	picrotoxin,126,136,Chemical/Drug	pentylenetetrazol,142,159,Chemical/Drug	GABA,258,262,Chemical/Drug	"[{""token"": ""beta - CCM"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazol"", ""start_span"": 142, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 258, ""end_span"": 262, ""type"": ""Chemical/Drug""}]"	train
Patients who experienced a manic or hypomanic switch were compared with those who did not on several variables including age, sex, diagnosis ( DSM - IV bipolar I vs. bipolar II), number of previous manic episodes, type of antidepressant therapy used ( electroconvulsive therapy vs. antidepressant drugs and, more particularly, selective serotonin reuptake inhibitors [ SSRIs]), use and type of mood stabilizers ( lithium vs. anticonvulsants), and temperament of the patient, assessed during a normothymic period using the hyperthymia component of the Semi - structured Affective Temperament Interview.	antidepressant,222,236,Chemical/Drug	antidepressant,282,296,Chemical/Drug	serotonin reuptake inhibitors,337,366,Chemical/Drug	SSRIs,369,374,Chemical/Drug	lithium,413,420,Chemical/Drug	"[{""token"": ""antidepressant"", ""start_span"": 222, ""end_span"": 236, ""type"": ""Chemical/Drug""}, {""token"": ""antidepressant"", ""start_span"": 282, ""end_span"": 296, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin reuptake inhibitors"", ""start_span"": 337, ""end_span"": 366, ""type"": ""Chemical/Drug""}, {""token"": ""SSRIs"", ""start_span"": 369, ""end_span"": 374, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 413, ""end_span"": 420, ""type"": ""Chemical/Drug""}]"	train
The aim of this study was to examine further the renal function, including morphological analysis of the kidneys of male Sprague - Dawley rats treated with either cyclosporine A ( CsA), tacrolimus ( FK506) or SRL as monotherapies or in different combinations.	cyclosporine A,163,177,Chemical/Drug	CsA,180,183,Chemical/Drug	tacrolimus,186,196,Chemical/Drug	FK506,199,204,Chemical/Drug	SRL,209,212,Chemical/Drug	"[{""token"": ""cyclosporine A"", ""start_span"": 163, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""tacrolimus"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	train
A further deterioration was seen when CsA was combined with either FK506 or SRL, whereas the GFR remained unchanged in the group treated with FK506 plus SRL when compared with treatment with any of the single substances.	CsA,38,41,Chemical/Drug	FK506,67,72,Chemical/Drug	SRL,76,79,Chemical/Drug	FK506,142,147,Chemical/Drug	SRL,153,156,Chemical/Drug	"[{""token"": ""CsA"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	train
A single MPEP ( 5 mg / kg ip) injection reduced the basal extracellular dopamine level in the striatum, as well as dopamine release stimulated either by methamphetamine ( 10 mg / kg sc) or by intrastriatally administered veratridine ( 100 microM).	MPEP,9,13,Chemical/Drug	dopamine,72,80,Chemical/Drug	dopamine,115,123,Chemical/Drug	methamphetamine,153,168,Chemical/Drug	veratridine,221,232,Chemical/Drug	"[{""token"": ""MPEP"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 153, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""veratridine"", ""start_span"": 221, ""end_span"": 232, ""type"": ""Chemical/Drug""}]"	train
The present study was designed to evaluate two endogenous and one synthetic neuroactive steroid that positively modulate the gamma - aminobutyric acid ( GABA ( A)) receptor against the increase in sensitivity to the convulsant effects of cocaine engendered by repeated cocaine administration ( seizure kindling).	steroid,88,95,Chemical/Drug	gamma - aminobutyric acid,125,150,Chemical/Drug	GABA,153,157,Chemical/Drug	cocaine,238,245,Chemical/Drug	cocaine,269,276,Chemical/Drug	"[{""token"": ""steroid"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""gamma - aminobutyric acid"", ""start_span"": 125, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 238, ""end_span"": 245, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 269, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	train
Depletion of dopamine in the striatum was also antagonized when LY274614 was given after the injection of amphetamine; LY274614 protected when given up to 4 hr after but not when given 8 or 24 hr after amphetamine.	dopamine,13,21,Chemical/Drug	LY274614,64,72,Chemical/Drug	amphetamine,106,117,Chemical/Drug	LY274614,119,127,Chemical/Drug	amphetamine,202,213,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 202, ""end_span"": 213, ""type"": ""Chemical/Drug""}]"	train
The data strengthen the evidence that the neurotoxic effect of amphetamine and related compounds toward nigrostriatal dopamine neurons involves NMDA receptors and that LY274614 is an NMDA receptor antagonist with long - lasting in vivo effects in rats.	amphetamine,63,74,Chemical/Drug	dopamine,118,126,Chemical/Drug	NMDA,144,148,Chemical/Drug	LY274614,168,176,Chemical/Drug	NMDA,183,187,Chemical/Drug	"[{""token"": ""amphetamine"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Chemical/Drug""}]"	train
When CPA, diazepam or 2PAM was given immediately after DFP - atropine, these treatments prevented, delayed or shortened the occurrence of serious signs of poisoning.	CPA,5,8,Chemical/Drug	diazepam,10,18,Chemical/Drug	2PAM,22,26,Chemical/Drug	DFP,55,58,Chemical/Drug	atropine,61,69,Chemical/Drug	"[{""token"": ""CPA"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""2PAM"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Chemical/Drug""}]"	train
In conclusion, CPA, diazepam and 2PAM in combination with atropine prevented the occurrence of serious signs of poisoning and thus reduced the toxicity of DFP in rat.	CPA,15,18,Chemical/Drug	diazepam,20,28,Chemical/Drug	2PAM,33,37,Chemical/Drug	atropine,58,66,Chemical/Drug	DFP,155,158,Chemical/Drug	"[{""token"": ""CPA"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""2PAM"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Chemical/Drug""}]"	train
STUDY DESIGN: We combined paclitaxel, melphalan and high - dose cyclophosphamide, thiotepa, and carboplatin in a triple sequential high - dose regimen for patients with metastatic breast cancer.	paclitaxel,26,36,Chemical/Drug	melphalan,38,47,Chemical/Drug	cyclophosphamide,64,80,Chemical/Drug	thiotepa,82,90,Chemical/Drug	carboplatin,96,107,Chemical/Drug	"[{""token"": ""paclitaxel"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""melphalan"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""thiotepa"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""carboplatin"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	train
The finding that cocaine - and BE - induced seizures differ in several respects suggests more than one mechanism for cocaine - induced seizures and emphasizes the importance of a cocaine metabolite, BE.	cocaine,17,24,Chemical/Drug	BE,31,33,Chemical/Drug	cocaine,117,124,Chemical/Drug	cocaine,179,186,Chemical/Drug	BE,199,201,Chemical/Drug	"[{""token"": ""cocaine"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""BE"", ""start_span"": 31, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Chemical/Drug""}, {""token"": ""BE"", ""start_span"": 199, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
Fewer subjects reported adverse events following treatment with desipramine alone than when receiving desipramine with cinacalcet ( 33 versus 86%), the most frequent of which ( nausea and headache) have been reported for patients treated with either desipramine or cinacalcet.	desipramine,64,75,Chemical/Drug	desipramine,102,113,Chemical/Drug	cinacalcet,119,129,Chemical/Drug	desipramine,250,261,Chemical/Drug	cinacalcet,265,275,Chemical/Drug	"[{""token"": ""desipramine"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""cinacalcet"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 250, ""end_span"": 261, ""type"": ""Chemical/Drug""}, {""token"": ""cinacalcet"", ""start_span"": 265, ""end_span"": 275, ""type"": ""Chemical/Drug""}]"	train
The ACTIVE - W ( Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy ( clopidogrel plus aspirin) in the prevention af embolic events.	Clopidogrel,37,48,Chemical/Drug	Irbesartan,60,70,Chemical/Drug	warfarin,134,142,Chemical/Drug	clopidogrel,177,188,Chemical/Drug	aspirin,194,201,Chemical/Drug	"[{""token"": ""Clopidogrel"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""Irbesartan"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""warfarin"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
The muscarinic receptor antagonists atropine, 4 - diphenylacetoxy - N - methylpiperidine ( 4 - DAMP) ( ' M ( 1) / M ( 3) / M ( 5) - selective '), methoctramine ( ' M ( 2) - selective ') and pirenzepine ( ' M ( 1) - selective ') antagonized the tonic component of the electrical field stimulation - evoked contractile response more potently than the phasic component.	atropine,36,44,Chemical/Drug	4 - diphenylacetoxy - N - methylpiperidine,46,88,Chemical/Drug	4 - DAMP,91,99,Chemical/Drug	methoctramine,146,159,Chemical/Drug	pirenzepine,190,201,Chemical/Drug	"[{""token"": ""atropine"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""4 - diphenylacetoxy - N - methylpiperidine"", ""start_span"": 46, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""4 - DAMP"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""methoctramine"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""pirenzepine"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
Thirty male Sprague - Dawley rats were divided randomly into four treatment groups: saline, dexamethasone ( dex), allopurinol plus saline, and allopurinol plus dex.	dexamethasone,92,105,Chemical/Drug	dex,108,111,Chemical/Drug	allopurinol,114,125,Chemical/Drug	allopurinol,143,154,Chemical/Drug	dex,160,163,Chemical/Drug	"[{""token"": ""dexamethasone"", ""start_span"": 92, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""dex"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""allopurinol"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""allopurinol"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""dex"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Chemical/Drug""}]"	train
Moreover, systemic lipopolysaccharide pretreatment ( 1 mg / kg) attenuated local methamphetamine infusion - produced dopamine and 3, 4 - dihydroxyphenylacetic acid depletions in the striatum, indicating that the protective effect of lipopolysaccharide is less likely due to interrupted peripheral distribution or metabolism of methamphetamine.	lipopolysaccharide,19,37,Chemical/Drug	methamphetamine,81,96,Chemical/Drug	dopamine,117,125,Chemical/Drug	lipopolysaccharide,233,251,Chemical/Drug	methamphetamine,327,342,Chemical/Drug	"[{""token"": ""lipopolysaccharide"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""lipopolysaccharide"", ""start_span"": 233, ""end_span"": 251, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 327, ""end_span"": 342, ""type"": ""Chemical/Drug""}]"	train
Laboratory evaluation revealed 66, 680 U / L creatine kinase, 93 mg / dL blood urea nitrogen, 4. 6 mg / dL creatinine, 1579 U / L aspartate aminotransferase, and 738 U / L alanine aminotransferase.	creatine,45,53,Chemical/Drug	blood urea nitrogen,73,92,Chemical/Drug	creatinine,107,117,Chemical/Drug	aspartate,130,139,Chemical/Drug	alanine,172,179,Chemical/Drug	"[{""token"": ""creatine"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""blood urea nitrogen"", ""start_span"": 73, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""alanine"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	train
In vivo microdialysis demonstrated that an intraperitoneal administration of pilocarpine induced a pronounced increment of hippocampal glutamate and aspartate whereas no significant change was observed on the level of glycine and GABA.	pilocarpine,77,88,Chemical/Drug	glutamate,135,144,Chemical/Drug	aspartate,149,158,Chemical/Drug	glycine,218,225,Chemical/Drug	GABA,230,234,Chemical/Drug	"[{""token"": ""pilocarpine"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
Pretreatment with either VPU ( 50 and 100 mg / kg) or VPA ( 300 and 600 mg / kg) completely abolished pilocarpine - evoked increases in extracellular glutamate and aspartate.	VPU,25,28,Chemical/Drug	VPA,54,57,Chemical/Drug	pilocarpine,102,113,Chemical/Drug	glutamate,150,159,Chemical/Drug	aspartate,164,173,Chemical/Drug	"[{""token"": ""VPU"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""VPA"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 150, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	train
Adult male albino rats, treated with ISO ( 200 mg / kg, s. c.) for 2 days at an interval of 24 h caused a significant ( P < 0. 05) elevation of heart weight, serum marker enzymes, lipid peroxidation and Ca + 2 ATPase level whereas there was a significant ( P < 0. 05) decrease in body weight, endogenous antioxidants, Na + / K + ATPase and Mg + 2 ATPase levels.	ISO,37,40,Chemical/Drug	Ca,203,205,Chemical/Drug	Na,318,320,Chemical/Drug	K,325,326,Chemical/Drug	Mg,340,342,Chemical/Drug	"[{""token"": ""ISO"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 203, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 318, ""end_span"": 320, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 325, ""end_span"": 326, ""type"": ""Chemical/Drug""}, {""token"": ""Mg"", ""start_span"": 340, ""end_span"": 342, ""type"": ""Chemical/Drug""}]"	train
Analysis of neurotransmitter concentration in some brain regions on the test day showed that dopamine concentration of the vehicle / scopolamine group was significantly lower than that of the vehicle / vehicle group, but this phenomenon was reversed when s - limonene or s - perillyl alcohol were administered before the injection of scopolamine.	dopamine,93,101,Chemical/Drug	scopolamine,133,144,Chemical/Drug	s - limonene,255,267,Chemical/Drug	s - perillyl alcohol,271,291,Chemical/Drug	scopolamine,334,345,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""s - limonene"", ""start_span"": 255, ""end_span"": 267, ""type"": ""Chemical/Drug""}, {""token"": ""s - perillyl alcohol"", ""start_span"": 271, ""end_span"": 291, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 334, ""end_span"": 345, ""type"": ""Chemical/Drug""}]"	train
Among them are glycine transporter - 1 ( GlyT1) inhibitors such as SSR103800, which indirectly enhance NMDA receptor function by increasing the glycine ( a co - agonist for the NMDA receptor) levels in the synapse.	glycine,15,22,Chemical/Drug	SSR103800,67,76,Chemical/Drug	NMDA,103,107,Chemical/Drug	glycine,144,151,Chemical/Drug	NMDA,177,181,Chemical/Drug	"[{""token"": ""glycine"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""SSR103800"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Chemical/Drug""}]"	train
Adriamycinol, doxorubicin, adriamycinone, and tetrahydropyranyladriamycinol were the metabolites detected in plasma and the amount of doxorubicin was less than or equal to 10% of the total metabolites.	Adriamycinol,0,12,Chemical/Drug	doxorubicin,14,25,Chemical/Drug	adriamycinone,27,40,Chemical/Drug	tetrahydropyranyladriamycinol,46,75,Chemical/Drug	doxorubicin,134,145,Chemical/Drug	"[{""token"": ""Adriamycinol"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""adriamycinone"", ""start_span"": 27, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""tetrahydropyranyladriamycinol"", ""start_span"": 46, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Chemical/Drug""}]"	train
Amnesia produced by scopolamine and cycloheximide were reversed by morphine given 30 min before the test trial ( pre - test), and pre - test morphine also facilitated the memory retrieval in the animals administered naloxone during the training trial.	scopolamine,20,31,Chemical/Drug	cycloheximide,36,49,Chemical/Drug	morphine,67,75,Chemical/Drug	morphine,141,149,Chemical/Drug	naloxone,216,224,Chemical/Drug	"[{""token"": ""scopolamine"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""cycloheximide"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""naloxone"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Chemical/Drug""}]"	train
During the infusion of aminophylline, the ventricular fibrillation threshold was reduced by 30 to 40 percent of the control when pH and partial pressures of oxygen ( PO2) and carbon dioxide ( CO2) were kept within normal limits.	aminophylline,23,36,Chemical/Drug	oxygen,157,163,Chemical/Drug	PO2,166,169,Chemical/Drug	carbon dioxide,175,189,Chemical/Drug	CO2,192,195,Chemical/Drug	"[{""token"": ""aminophylline"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""PO2"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""carbon dioxide"", ""start_span"": 175, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""CO2"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical/Drug""}]"	train
Pentoxifylline ( Trental) does not inhibit dipyridamole - induced coronary hyperemia: implications for dipyridamole - thallium - 201 myocardial imaging.	Pentoxifylline,0,14,Chemical/Drug	Trental,17,24,Chemical/Drug	dipyridamole,43,55,Chemical/Drug	dipyridamole,103,115,Chemical/Drug	thallium,118,126,Chemical/Drug	"[{""token"": ""Pentoxifylline"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""Trental"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""thallium"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	train
These data indicate that ( 1) the apparent incidence of stroke related to cocaine use is increasing; ( 2) cocaine - associated stroke occurs primarily in young adults; ( 3) stroke may follow any route of cocaine administration; ( 4) stroke after cocaine use is frequently associated with intracranial aneurysms and arteriovenous malformations; and ( 5) in cocaine - associated stroke, the frequency of intracranial hemorrhage exceeds that of cerebral infarction.	cocaine,74,81,Chemical/Drug	cocaine,106,113,Chemical/Drug	cocaine,204,211,Chemical/Drug	cocaine,246,253,Chemical/Drug	cocaine,356,363,Chemical/Drug	"[{""token"": ""cocaine"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 356, ""end_span"": 363, ""type"": ""Chemical/Drug""}]"	train
Application of a delayed feedback signal, in the form of a 2 - h systemic corticosterone infusion in urethane - anesthetized rats with pharmacological blockade of glucocorticoid synthesis, is without effect on the resting secretion of arginine vasopressin and oxytocin at any corticosterone feedback dose tested.	corticosterone,74,88,Chemical/Drug	urethane,101,109,Chemical/Drug	arginine vasopressin,235,255,Chemical/Drug	oxytocin,260,268,Chemical/Drug	corticosterone,276,290,Chemical/Drug	"[{""token"": ""corticosterone"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""urethane"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""arginine vasopressin"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Chemical/Drug""}, {""token"": ""oxytocin"", ""start_span"": 260, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""corticosterone"", ""start_span"": 276, ""end_span"": 290, ""type"": ""Chemical/Drug""}]"	train
The multiple drug schema consisted of: Etoposide 16. 213, Methotrexate, Cyclophosphamide, Actomycin - D, and Cisplatin.	Etoposide,39,48,Chemical/Drug	Methotrexate,58,70,Chemical/Drug	Cyclophosphamide,72,88,Chemical/Drug	Actomycin - D,90,103,Chemical/Drug	Cisplatin,109,118,Chemical/Drug	"[{""token"": ""Etoposide"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""Methotrexate"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""Cyclophosphamide"", ""start_span"": 72, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""Actomycin - D"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""Cisplatin"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Chemical/Drug""}]"	train
The effects of varying the extracellular concentrations of Na and Ca ( [ Na] o and [ Ca] o) on both, the spontaneous beating and the negative chronotropic action of verapamil, were studied in the isolated rat atria.	Na,59,61,Chemical/Drug	Ca,66,68,Chemical/Drug	Na,73,75,Chemical/Drug	Ca,85,87,Chemical/Drug	verapamil,165,174,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 85, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Chemical/Drug""}]"	train
It decreased by 16 + / - 3% by lowering [ Na] o to 78 mM ( LNa), 23 + / - 2% by lowering simultaneously [ Na] o to 78 mM and [ Ca] o to 0. 675 mM ( LNa + LCa) and 31 + / - 5% by lowering [ Na] o to 78 mM plus increasing [ Ca] o to 3. 6 mM ( LNa + HCa).	Na,42,44,Chemical/Drug	Na,60,62,Chemical/Drug	Ca,127,129,Chemical/Drug	Na,149,151,Chemical/Drug	Ca,155,157,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 60, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 127, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
The pathogenesis of 5 - fluorouracil neurotoxicity may be due to a Krebs cycle blockade by fluoroacetate and fluorocitrate, thiamine deficiency, or dihydrouracil dehydrogenase deficiency.	5 - fluorouracil,20,36,Chemical/Drug	fluoroacetate,91,104,Chemical/Drug	fluorocitrate,109,122,Chemical/Drug	thiamine,124,132,Chemical/Drug	dihydrouracil,148,161,Chemical/Drug	"[{""token"": ""5 - fluorouracil"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""fluoroacetate"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""fluorocitrate"", ""start_span"": 109, ""end_span"": 122, ""type"": ""Chemical/Drug""}, {""token"": ""thiamine"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""dihydrouracil"", ""start_span"": 148, ""end_span"": 161, ""type"": ""Chemical/Drug""}]"	train
Carbamazepine was switched to its 10 - keto analogue oxcarbazepine among six difficult - to - treat schizophrenic or organic psychotic patients using concomitantly haloperidol, chlorpromazine or clozapine.	Carbamazepine,0,13,Chemical/Drug	oxcarbazepine,53,66,Chemical/Drug	haloperidol,164,175,Chemical/Drug	chlorpromazine,177,191,Chemical/Drug	clozapine,195,204,Chemical/Drug	"[{""token"": ""Carbamazepine"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""oxcarbazepine"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Chemical/Drug""}, {""token"": ""chlorpromazine"", ""start_span"": 177, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Chemical/Drug""}]"	train
For each of the three tested calcium channel blockers ( diltiazem, verapamil and bepridil) 6 groups of mice were treated by two different doses, i. e. 2 and 10 mg / kg / i. p., or an equal volume of saline for the control group ( n = 20); 15 minutes later, all the animals were injected with a single 50 mg / kg / i. p. dose of bupivacaine.	calcium,29,36,Chemical/Drug	diltiazem,56,65,Chemical/Drug	verapamil,67,76,Chemical/Drug	bepridil,81,89,Chemical/Drug	bupivacaine,328,339,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 56, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""bepridil"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 328, ""end_span"": 339, ""type"": ""Chemical/Drug""}]"	train
To evaluate the effect of prostaglandin E1 ( PGE1) or trimethaphan ( TMP) induced hypotension on epidural blood flow ( EBF) during spinal surgery, EBF was measured using the heat clearance method in 30 patients who underwent postero - lateral interbody fusion under isoflurane anaesthesia.	prostaglandin E1,26,42,Chemical/Drug	PGE1,45,49,Chemical/Drug	trimethaphan,54,66,Chemical/Drug	TMP,69,72,Chemical/Drug	isoflurane,266,276,Chemical/Drug	"[{""token"": ""prostaglandin E1"", ""start_span"": 26, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""PGE1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""trimethaphan"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""TMP"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 266, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	train
The appearance of nephrotic syndromes such as proteinuria, hypoalbuminemia, hypercholesterolemia and increase in blood nitrogen urea, induced in rats by injection of puromycin aminonucleoside was markedly inhibited by oral administration of Dup 753 ( losartan), a novel angiotensin II receptor antagonist, at a dose of 1 or 2 mg / kg per day.	blood nitrogen urea,113,132,Chemical/Drug	puromycin aminonucleoside,166,191,Chemical/Drug	Dup 753,241,248,Chemical/Drug	losartan,251,259,Chemical/Drug	angiotensin II,270,284,Chemical/Drug	"[{""token"": ""blood nitrogen urea"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""puromycin aminonucleoside"", ""start_span"": 166, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""Dup 753"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Chemical/Drug""}, {""token"": ""losartan"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin II"", ""start_span"": 270, ""end_span"": 284, ""type"": ""Chemical/Drug""}]"	train
After the administration of NG, 5 - FU and CY neither a statistically significant increase in creatinine concentration nor an increase in creatinine clearance was observed compared to the group receiving no cytostatics.	NG,28,30,Chemical/Drug	5 - FU,32,38,Chemical/Drug	CY,43,45,Chemical/Drug	creatinine,94,104,Chemical/Drug	creatinine,138,148,Chemical/Drug	"[{""token"": ""NG"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""CY"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: Hydrochlorofluorocarbons ( HCFCs) are used increasingly in industry as substitutes for ozone - depleting chlorofluorocarbons ( CFCs).	Hydrochlorofluorocarbons,12,36,Chemical/Drug	HCFCs,39,44,Chemical/Drug	ozone,99,104,Chemical/Drug	chlorofluorocarbons,117,136,Chemical/Drug	CFCs,139,143,Chemical/Drug	"[{""token"": ""Hydrochlorofluorocarbons"", ""start_span"": 12, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""HCFCs"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""ozone"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""chlorofluorocarbons"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""CFCs"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Chemical/Drug""}]"	train
Combination chemotherapy with mitoxantrone, high - dose 5 - fluorouracil ( 5 - FU) and leucovorin ( MFL regimen) had been reported as an effective and well tolerated regimen.	mitoxantrone,30,42,Chemical/Drug	5 - fluorouracil,56,72,Chemical/Drug	5 - FU,75,81,Chemical/Drug	leucovorin,87,97,Chemical/Drug	MFL regimen,100,111,Chemical/Drug	"[{""token"": ""mitoxantrone"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""5 - fluorouracil"", ""start_span"": 56, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""leucovorin"", ""start_span"": 87, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""MFL regimen"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	train
Mitochondrial radiocalcium uptakes were significantly decreased in animals pretreated with acetylsalicylic acid or dipyridamole or when hydrocortisone was added to the epinephrine infusion ( 2, 682, 2, 803, and 3, 424 counts per minute per gram of dried fraction, respectively).	radiocalcium,14,26,Chemical/Drug	acetylsalicylic acid,91,111,Chemical/Drug	dipyridamole,115,127,Chemical/Drug	hydrocortisone,136,150,Chemical/Drug	epinephrine,168,179,Chemical/Drug	"[{""token"": ""radiocalcium"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""acetylsalicylic acid"", ""start_span"": 91, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""hydrocortisone"", ""start_span"": 136, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 168, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	train
We recently showed elevated reactive oxygen species ( ROS), reduced urinary excretion of NO metabolites ( NOx), and increased NO sequestration as nitrotyrosine in various tissues in rats with lead - induced hypertension.	oxygen,37,43,Chemical/Drug	NO,89,91,Chemical/Drug	NO,106,108,Chemical/Drug	nitrotyrosine,146,159,Chemical/Drug	lead,192,196,Chemical/Drug	"[{""token"": ""oxygen"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""nitrotyrosine"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""lead"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Chemical/Drug""}]"	valid
Male Sprague - Dawley rats were randomly assigned to a lead - treated group ( given lead acetate, 100 ppm, in drinking water and regular rat chow), a group given lead and vitamin E - fortified chow, or a normal control group given either regular food and water or vitamin E - fortified food for 12 weeks.	lead,55,59,Chemical/Drug	lead acetate,84,96,Chemical/Drug	lead,162,166,Chemical/Drug	vitamin E,171,180,Chemical/Drug	vitamin E,264,273,Chemical/Drug	"[{""token"": ""lead"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""lead acetate"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""lead"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 264, ""end_span"": 273, ""type"": ""Chemical/Drug""}]"	valid
BACKGROUND: The aim of this study is to evaluate the effects of RAPA conversion in patients undergoing cyclosporine ( CsA) or tacrolimus ( Tac) toxicity.	RAPA,64,68,Chemical/Drug	cyclosporine,103,115,Chemical/Drug	CsA,118,121,Chemical/Drug	tacrolimus,126,136,Chemical/Drug	Tac,139,142,Chemical/Drug	"[{""token"": ""RAPA"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""cyclosporine"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""tacrolimus"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""Tac"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical/Drug""}]"	valid
The patients concurrent medications included didanosine, hydroxyzine, promethazine, hydrocortisone, and prochlorperazine.	didanosine,45,55,Chemical/Drug	hydroxyzine,57,68,Chemical/Drug	promethazine,70,82,Chemical/Drug	hydrocortisone,84,98,Chemical/Drug	prochlorperazine,104,120,Chemical/Drug	"[{""token"": ""didanosine"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""hydroxyzine"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""promethazine"", ""start_span"": 70, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""hydrocortisone"", ""start_span"": 84, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""prochlorperazine"", ""start_span"": 104, ""end_span"": 120, ""type"": ""Chemical/Drug""}]"	valid
Intracerebroventricular injection of atropine, hexamethonium, and naloxone also decreased catalepsy induced by morphine plus nicotine.	atropine,37,45,Chemical/Drug	hexamethonium,47,60,Chemical/Drug	naloxone,66,74,Chemical/Drug	morphine,111,119,Chemical/Drug	nicotine,125,133,Chemical/Drug	"[{""token"": ""atropine"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""hexamethonium"", ""start_span"": 47, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""naloxone"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Chemical/Drug""}]"	valid
From day 0 to day 3, the mean peak increase in creatinine was 0. 13 mg per deciliter in the iodixanol group and 0. 55 mg per deciliter in the iohexol group ( P = 0. 001; the increase with iodixanol minus the increase with iohexol, - 0. 42 mg per deciliter [ 95 percent confidence interval, - 0. 73 to - 0. 22]).	creatinine,47,57,Chemical/Drug	iodixanol,92,101,Chemical/Drug	iohexol,142,149,Chemical/Drug	iodixanol,188,197,Chemical/Drug	iohexol,222,229,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 222, ""end_span"": 229, ""type"": ""Chemical/Drug""}]"	valid
The mean change in the creatinine concentration from day 0 to day 7 was 0. 07 mg per deciliter in the iodixanol group and 0. 24 mg per deciliter in the iohexol group ( P = 0. 003; value in the iodixanol group minus the value in the iohexol group, - 0. 17 mg per deciliter [ 95 percent confidence interval, - 0. 34 to - 0. 07]).	creatinine,23,33,Chemical/Drug	iodixanol,102,111,Chemical/Drug	iohexol,152,159,Chemical/Drug	iodixanol,193,202,Chemical/Drug	iohexol,232,239,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Chemical/Drug""}]"	valid
Similarly, when the P450 - mediated metabolism of lindane was blocked by cobalt chloride incidence of convulsions was increased in animals treated with lindane indicating that lindane per se or its metabolites formed by PB or ethanol inducible P450 isoenzymes are involved in its neurobehavioral toxicity.	lindane,50,57,Chemical/Drug	cobalt chloride,73,88,Chemical/Drug	lindane,152,159,Chemical/Drug	lindane,176,183,Chemical/Drug	ethanol,226,233,Chemical/Drug	"[{""token"": ""lindane"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""cobalt chloride"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""lindane"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""lindane"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Chemical/Drug""}]"	valid
The corresponding absolute risk of VTE was 3. 4 ( range, 3. 1 - 3. 8) per 10 000 women years among the women on COCs, 4. 2 ( range, 3. 2 - 5. 2) per 10 000 women years among women on levonorgestrel - containing COCs, and 3. 1 ( range, 1. 3 - 4. 9) per 10 000 women years among the women on CPA / EE.	COCs,112,116,Chemical/Drug	levonorgestrel,183,197,Chemical/Drug	COCs,211,215,Chemical/Drug	CPA,290,293,Chemical/Drug	EE,296,298,Chemical/Drug	"[{""token"": ""COCs"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""levonorgestrel"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""COCs"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Chemical/Drug""}, {""token"": ""CPA"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Chemical/Drug""}, {""token"": ""EE"", ""start_span"": 296, ""end_span"": 298, ""type"": ""Chemical/Drug""}]"	valid
Flumazenil ( mean dose, 0. 76 mg) or placebo ( mean dose, 8. 9 ml) was administered intravenously to 130 and 67 patients, respectively, who had been given diazepam in conjunction with an opioid ( fentanyl, meperidine, or morphine) for the induction and maintenance of intravenous conscious sedation for diagnostic or therapeutic surgical procedures.	Flumazenil,0,10,Chemical/Drug	diazepam,155,163,Chemical/Drug	fentanyl,196,204,Chemical/Drug	meperidine,206,216,Chemical/Drug	morphine,221,229,Chemical/Drug	"[{""token"": ""Flumazenil"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""meperidine"", ""start_span"": 206, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 221, ""end_span"": 229, ""type"": ""Chemical/Drug""}]"	valid
On the other hand, bicuculline, aminophylline and BAY k - 8644 inhibited the anticonvulsive action of loreclezole combined with clonazepam.	bicuculline,19,30,Chemical/Drug	aminophylline,32,45,Chemical/Drug	BAY k - 8644,50,62,Chemical/Drug	loreclezole,102,113,Chemical/Drug	clonazepam,128,138,Chemical/Drug	"[{""token"": ""bicuculline"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""aminophylline"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""BAY k - 8644"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""loreclezole"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""clonazepam"", ""start_span"": 128, ""end_span"": 138, ""type"": ""Chemical/Drug""}]"	valid
PURPOSE: The anthracyclines daunorubicin and doxorubicin and the epipodophyllotoxin etoposide are potent DNA cleavage - enhancing drugs that are widely used in clinical oncology; however, myelosuppression and cardiac toxicity limit their use.	anthracyclines,13,27,Chemical/Drug	daunorubicin,28,40,Chemical/Drug	doxorubicin,45,56,Chemical/Drug	epipodophyllotoxin,65,83,Chemical/Drug	etoposide,84,93,Chemical/Drug	"[{""token"": ""anthracyclines"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""epipodophyllotoxin"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Chemical/Drug""}]"	valid
EXPERIMENTAL DESIGN: Because of their widespread use, the hematologic toxicity following coadministration of dexrazoxane and these three structurally different DNA cleavage enhancers was investigated: Sensitivity of human and murine blood progenitor cells to etoposide, daunorubicin, and doxorubicin + / - dexrazoxane was determined in granulocyte - macrophage colony forming assays.	dexrazoxane,109,120,Chemical/Drug	etoposide,259,268,Chemical/Drug	daunorubicin,270,282,Chemical/Drug	doxorubicin,288,299,Chemical/Drug	dexrazoxane,306,317,Chemical/Drug	"[{""token"": ""dexrazoxane"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 259, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 288, ""end_span"": 299, ""type"": ""Chemical/Drug""}, {""token"": ""dexrazoxane"", ""start_span"": 306, ""end_span"": 317, ""type"": ""Chemical/Drug""}]"	valid
RESULTS: Nontoxic doses of dexrazoxane reduced myelosuppression and weight loss from daunorubicin and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, dexrazoxane neither reduced myelosuppression, weight loss, nor the in vitro cytotoxicity from doxorubicin.	dexrazoxane,27,38,Chemical/Drug	daunorubicin,85,97,Chemical/Drug	etoposide,102,111,Chemical/Drug	dexrazoxane,198,209,Chemical/Drug	doxorubicin,292,303,Chemical/Drug	"[{""token"": ""dexrazoxane"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""dexrazoxane"", ""start_span"": 198, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 292, ""end_span"": 303, ""type"": ""Chemical/Drug""}]"	valid
Subcutaneous injection of ISPH ( 200 mg / kg body weight in 1 ml saline) to rats for 2 consecutive days caused myocardial damage in rat heart, which was determined by the increased activity of serum lactate dehydrogenase ( LDH) and creatine phosphokinase isoenzymes ( CK - MB), increased uric acid level and reduced plasma iron binding capacity.	ISPH,26,30,Chemical/Drug	lactate,199,206,Chemical/Drug	creatine,232,240,Chemical/Drug	uric acid,288,297,Chemical/Drug	iron,323,327,Chemical/Drug	"[{""token"": ""ISPH"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Chemical/Drug""}, {""token"": ""creatine"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 288, ""end_span"": 297, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 323, ""end_span"": 327, ""type"": ""Chemical/Drug""}]"	valid
Co - administration of lidocaine with desipramine reversed the changes of convulsive activity of lidocaine and cocaine induced by repeated administration of desipramine.	lidocaine,23,32,Chemical/Drug	desipramine,38,49,Chemical/Drug	lidocaine,97,106,Chemical/Drug	cocaine,111,118,Chemical/Drug	desipramine,157,168,Chemical/Drug	"[{""token"": ""lidocaine"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	valid
To assess the antioxidant effects of atorvastatin ( atorva) on dexamethasone ( dex) - induced hypertension, 60 male Sprague - Dawley rats were treated with atorva 30 mg / kg / day or tap water for 15 days.	atorvastatin,37,49,Chemical/Drug	atorva,52,58,Chemical/Drug	dexamethasone,63,76,Chemical/Drug	dex,79,82,Chemical/Drug	atorva,156,162,Chemical/Drug	"[{""token"": ""atorvastatin"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""atorva"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""dex"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""atorva"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	valid
D - 1 agonist SKF 38393 or D - 2 agonist quinpirole decreased the catalepsy induced by fluphenazine, SCH 23390 or sulpiride.	SKF 38393,14,23,Chemical/Drug	quinpirole,41,51,Chemical/Drug	fluphenazine,87,99,Chemical/Drug	SCH 23390,101,110,Chemical/Drug	sulpiride,114,123,Chemical/Drug	"[{""token"": ""SKF 38393"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""quinpirole"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""fluphenazine"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""SCH 23390"", ""start_span"": 101, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""sulpiride"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Chemical/Drug""}]"	valid
Similarly, EPS - related adverse events with QTP + Li / DVP ( 21. 4%) were no different than with PBO + Li / DVP ( 19. 2%).	QTP,45,48,Chemical/Drug	Li,51,53,Chemical/Drug	DVP,56,59,Chemical/Drug	Li,104,106,Chemical/Drug	DVP,109,112,Chemical/Drug	"[{""token"": ""QTP"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""Li"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""DVP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""Li"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""DVP"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Chemical/Drug""}]"	valid
To demonstrate the relationship between peripheral iron overload and dopaminergic neuron loss in rat substantia nigra ( SN), in the present study we used fast cyclic voltammetry, tyrosine hydroxylase ( TH) immunohistochemistry, Perls ' iron staining, and high performance liquid chromatography - electrochemical detection to study the degeneration of dopaminergic neurons and increased iron content in the SN of iron dextran overloaded animals.	iron,51,55,Chemical/Drug	tyrosine,179,187,Chemical/Drug	iron,236,240,Chemical/Drug	iron,386,390,Chemical/Drug	iron dextran,412,424,Chemical/Drug	"[{""token"": ""iron"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""tyrosine"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 236, ""end_span"": 240, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 386, ""end_span"": 390, ""type"": ""Chemical/Drug""}, {""token"": ""iron dextran"", ""start_span"": 412, ""end_span"": 424, ""type"": ""Chemical/Drug""}]"	valid
Blood samples for the analysis of plasma potassium, terbutaline, metoprolol ( racemic, R - and S - isomer), and alpha - hydroxymetoprolol concentrations were taken at regular time intervals, during 8 hr after metoprolol.	potassium,41,50,Chemical/Drug	terbutaline,52,63,Chemical/Drug	metoprolol,65,75,Chemical/Drug	alpha - hydroxymetoprolol,112,137,Chemical/Drug	metoprolol,209,219,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""terbutaline"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""metoprolol"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""alpha - hydroxymetoprolol"", ""start_span"": 112, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""metoprolol"", ""start_span"": 209, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	valid
Mechanistic studies revealed that OB rats are sensitized due to: ( 1) higher oxyradical stress leading to upregulation of uncoupling proteins 2 and 3, ( 2) downregulation of cardiac peroxisome proliferators activated receptor - alpha, ( 3) decreased plasma adiponectin levels, ( 4) decreased cardiac fatty - acid oxidation ( 666. 9 + / - 14. 0 nmol / min / g heart in ND versus 400. 2 + / - 11. 8 nmol / min / g heart in OB), ( 5) decreased mitochondrial AMP - alpha2 protein kinase, and ( 6) 86% drop in cardiac ATP levels accompanied by decreased ATP / ADP ratio after doxorubicin administration.	AMP,455,458,Chemical/Drug	ATP,513,516,Chemical/Drug	ATP,549,552,Chemical/Drug	ADP,555,558,Chemical/Drug	doxorubicin,571,582,Chemical/Drug	"[{""token"": ""AMP"", ""start_span"": 455, ""end_span"": 458, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 513, ""end_span"": 516, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 549, ""end_span"": 552, ""type"": ""Chemical/Drug""}, {""token"": ""ADP"", ""start_span"": 555, ""end_span"": 558, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 571, ""end_span"": 582, ""type"": ""Chemical/Drug""}]"	valid
The beneficial effects of vitamin C administration to gentamicin - treated animals are also confirmed through: lower level of blood urea and creatinine and higher level of potassium.	vitamin C,26,35,Chemical/Drug	gentamicin,54,64,Chemical/Drug	urea,132,136,Chemical/Drug	creatinine,141,151,Chemical/Drug	potassium,172,181,Chemical/Drug	"[{""token"": ""vitamin C"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""gentamicin"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 172, ""end_span"": 181, ""type"": ""Chemical/Drug""}]"	valid
Ninety - six Swiss - Webster mice ( 30 - 35 g, 6 - 8 wk), were randomized into 6 groups 1) saline ( control), 2) NTG immediately after learning, 3) NTG 3 h after learning, 4) NTG and NIMO, 5) vehicle, and 6) NIMO alone.	NTG,113,116,Chemical/Drug	NTG,148,151,Chemical/Drug	NTG,175,178,Chemical/Drug	NIMO,183,187,Chemical/Drug	NIMO,208,212,Chemical/Drug	"[{""token"": ""NTG"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""NTG"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""NTG"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""NIMO"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Chemical/Drug""}, {""token"": ""NIMO"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	valid
This prospective study determined the incidence of CIN for two nonionic contrast media ( CM), iopromide and iohexol, among 80 patients younger than 18 years and compared the rates for this complication in relation to the type and dosage of CM and the presence of cyanosis.	contrast media,72,86,Chemical/Drug	CM,89,91,Chemical/Drug	iopromide,94,103,Chemical/Drug	iohexol,108,115,Chemical/Drug	CM,240,242,Chemical/Drug	"[{""token"": ""contrast media"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""CM"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""iopromide"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""CM"", ""start_span"": 240, ""end_span"": 242, ""type"": ""Chemical/Drug""}]"	valid
Compound 1 is a potent A ( 2A) / A ( 1) receptor antagonist in vitro ( A ( 2A) K ( i) = 4. 1 nM; A ( 1) K ( i) = 17. 0 nM) that has excellent activity, after oral administration, across a number of animal models of Parkinson ' s disease including mouse and rat models of haloperidol - induced catalepsy, mouse model of reserpine - induced akinesia, rat 6 - hydroxydopamine ( 6 - OHDA) lesion model of drug - induced rotation, and MPTP - treated non - human primate model.	haloperidol,271,282,Chemical/Drug	reserpine,319,328,Chemical/Drug	6 - hydroxydopamine,353,372,Chemical/Drug	6 - OHDA,375,383,Chemical/Drug	MPTP,430,434,Chemical/Drug	"[{""token"": ""haloperidol"", ""start_span"": 271, ""end_span"": 282, ""type"": ""Chemical/Drug""}, {""token"": ""reserpine"", ""start_span"": 319, ""end_span"": 328, ""type"": ""Chemical/Drug""}, {""token"": ""6 - hydroxydopamine"", ""start_span"": 353, ""end_span"": 372, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 375, ""end_span"": 383, ""type"": ""Chemical/Drug""}, {""token"": ""MPTP"", ""start_span"": 430, ""end_span"": 434, ""type"": ""Chemical/Drug""}]"	valid
Pre - treatment with ketamine produced cross - tolerance to morphine, whereas pretreatment with morphine did not induce cross - tolerance to ketamine but rather augmented the cataleptic response; this augmentation was attributed to residual morphine in the brain.	ketamine,21,29,Chemical/Drug	morphine,60,68,Chemical/Drug	morphine,96,104,Chemical/Drug	ketamine,141,149,Chemical/Drug	morphine,241,249,Chemical/Drug	"[{""token"": ""ketamine"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 241, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	valid
25 mg / kg, i. v. thiopental produced anesthesia without altering respiratory rate, increased GABA, decreased glutamate, and had no effect on aspartate or glycine levels compared to controls in rat cortex and brain stem.	thiopental,18,28,Chemical/Drug	GABA,94,98,Chemical/Drug	glutamate,110,119,Chemical/Drug	aspartate,142,151,Chemical/Drug	glycine,155,162,Chemical/Drug	"[{""token"": ""thiopental"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	valid
In rats which were pretreated with nicotine for 5 days, there was a significant increase in the nicotine - stimulated locomotor response which was associated with an increase in the number of L - [ 3H] nicotine binding sites and also with an elevated dopamine ( DA) level in the striatum.	nicotine,35,43,Chemical/Drug	nicotine,96,104,Chemical/Drug	nicotine,202,210,Chemical/Drug	dopamine,251,259,Chemical/Drug	DA,262,264,Chemical/Drug	"[{""token"": ""nicotine"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 262, ""end_span"": 264, ""type"": ""Chemical/Drug""}]"	valid
Acute experimental models of renal damage to the proximal tubular, glomerular, and papillary regions of the rat were produced by administration of hexachloro - 1: 3 - butadiene ( HCBD), puromycin aminonucleoside ( PAN), and 2 - bromoethylamine ( BEA), respectively.	HCBD,179,183,Chemical/Drug	puromycin aminonucleoside,186,211,Chemical/Drug	PAN,214,217,Chemical/Drug	2 - bromoethylamine,224,243,Chemical/Drug	BEA,246,249,Chemical/Drug	"[{""token"": ""HCBD"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""puromycin aminonucleoside"", ""start_span"": 186, ""end_span"": 211, ""type"": ""Chemical/Drug""}, {""token"": ""PAN"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Chemical/Drug""}, {""token"": ""2 - bromoethylamine"", ""start_span"": 224, ""end_span"": 243, ""type"": ""Chemical/Drug""}, {""token"": ""BEA"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	valid
The combined administration of CSA and various chemotherapeutic drugs with a nephrotoxic potential, such as gentamicin ( at therapeutic doses), amphothericin B and ketoconazole, which are frequently used in immunosuppressed patients, did not aggravate the CSA induced toxicity in the rat model.	CSA,31,34,Chemical/Drug	gentamicin,108,118,Chemical/Drug	amphothericin B,144,159,Chemical/Drug	ketoconazole,164,176,Chemical/Drug	CSA,256,259,Chemical/Drug	"[{""token"": ""CSA"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""gentamicin"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""amphothericin B"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""ketoconazole"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""CSA"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Chemical/Drug""}]"	valid
Treatment with high doses of cimetidine ( one to 60 months; median, 11 months) or ranitidine ( two to 31 months; median, 14 months) was not associated with hepatic or hematologic toxicity or alterations of serum gastrin concentrations, but ranitidine therapy was associated with a significantly lower serum creatinine level than seen with cimetidine therapy.	cimetidine,29,39,Chemical/Drug	ranitidine,82,92,Chemical/Drug	ranitidine,240,250,Chemical/Drug	creatinine,307,317,Chemical/Drug	cimetidine,339,349,Chemical/Drug	"[{""token"": ""cimetidine"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""ranitidine"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""ranitidine"", ""start_span"": 240, ""end_span"": 250, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 307, ""end_span"": 317, ""type"": ""Chemical/Drug""}, {""token"": ""cimetidine"", ""start_span"": 339, ""end_span"": 349, ""type"": ""Chemical/Drug""}]"	valid
Pretreatment with ammonium acetate ( NH4Ac) ( 6 mmol / kg s. c.) approximately doubled the time morphine - treated mice remained on a hot surface and similarly increased muscular incoordination by diazepam, but NH4Ac treatment alone had no effect.	ammonium acetate,18,34,Chemical/Drug	NH4Ac,37,42,Chemical/Drug	morphine,96,104,Chemical/Drug	diazepam,197,205,Chemical/Drug	NH4Ac,211,216,Chemical/Drug	"[{""token"": ""ammonium acetate"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 197, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Chemical/Drug""}]"	valid
Experiments in vitro showed that acetylcholine - induced catecholamine release from bovine adrenal medulla is depressed as much as 50% by 0. 3 mM NH4Ac and KCl - induced contractions of guinea - pig ileum were inhibited 20% by 5 mM NH4Ac.	acetylcholine,33,46,Chemical/Drug	catecholamine,57,70,Chemical/Drug	NH4Ac,146,151,Chemical/Drug	KCl,156,159,Chemical/Drug	NH4Ac,232,237,Chemical/Drug	"[{""token"": ""acetylcholine"", ""start_span"": 33, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""KCl"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Chemical/Drug""}]"	valid
Addition of excess calcium reversed the depression in both tissues, but calcium - independent catecholamine release by acetaldehyde was not blocked by NH4Ac.	calcium,19,26,Chemical/Drug	calcium,72,79,Chemical/Drug	catecholamine,94,107,Chemical/Drug	acetaldehyde,119,131,Chemical/Drug	NH4Ac,151,156,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""acetaldehyde"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	valid
These results suggest that PGs are involved in the mechanism ( s) underlying fluorthyl - and PTZ - induced convulsions, but not picrotoxin -, electroshock -, or bicuculline - induced convulsions.	PGs,27,30,Chemical/Drug	fluorthyl,77,86,Chemical/Drug	PTZ,93,96,Chemical/Drug	picrotoxin,128,138,Chemical/Drug	bicuculline,161,172,Chemical/Drug	"[{""token"": ""PGs"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""fluorthyl"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""PTZ"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 128, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""bicuculline"", ""start_span"": 161, ""end_span"": 172, ""type"": ""Chemical/Drug""}]"	valid
Serotonin and N - acetyl serotonin which augmented ketamine DOC, did not do so in the absence of the pineal gland, whereas melatonin potentiated the ketamine DOC in both the intact and pinealectomized chick.	Serotonin,0,9,Chemical/Drug	N - acetyl serotonin,14,34,Chemical/Drug	ketamine,51,59,Chemical/Drug	melatonin,123,132,Chemical/Drug	ketamine,149,157,Chemical/Drug	"[{""token"": ""Serotonin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""N - acetyl serotonin"", ""start_span"": 14, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""melatonin"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	valid
A 31 - year - old man with rheumatoid arthritis, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and gold salts, developed renal papillary necrosis ( RPN) 4 months after institution of naproxen therapy.	sulindac,86,94,Chemical/Drug	fenoprofen calcium,96,114,Chemical/Drug	salicylates,126,137,Chemical/Drug	gold,142,146,Chemical/Drug	naproxen,226,234,Chemical/Drug	"[{""token"": ""sulindac"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""fenoprofen calcium"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""salicylates"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""gold"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""naproxen"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	valid
The effect of L - dopa was correlated with a decrease in blood and brain ammonia, an increase in brain dopamine, and an increase in renal excretion of ammonia and urea.	L - dopa,14,22,Chemical/Drug	ammonia,73,80,Chemical/Drug	dopamine,103,111,Chemical/Drug	ammonia,151,158,Chemical/Drug	urea,163,167,Chemical/Drug	"[{""token"": ""L - dopa"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	valid
While AAP caused a 117 - fold elevation of serum transaminase activities in mice kept on a standard laboratory diet, which was significantly exacerbated by ethanol and inhibited by nicotinic acid amide ( NAA), adverse effects were noted in animals fed a diet free of precursors of NAD.	AAP,6,9,Chemical/Drug	ethanol,156,163,Chemical/Drug	nicotinic acid amide,181,201,Chemical/Drug	NAA,204,207,Chemical/Drug	NAD,281,284,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""nicotinic acid amide"", ""start_span"": 181, ""end_span"": 201, ""type"": ""Chemical/Drug""}, {""token"": ""NAA"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Chemical/Drug""}, {""token"": ""NAD"", ""start_span"": 281, ""end_span"": 284, ""type"": ""Chemical/Drug""}]"	valid
In addition to its use as a stabilizer / rigidifier of membranes, cholesteryl hemisuccinate, tris salt ( CS) administration has also been shown to protect rats from the hepatotoxic effects of carbon tetrachloride ( CCl4).	cholesteryl hemisuccinate,66,91,Chemical/Drug	tris salt,93,102,Chemical/Drug	CS,105,107,Chemical/Drug	carbon tetrachloride,192,212,Chemical/Drug	CCl4,215,219,Chemical/Drug	"[{""token"": ""cholesteryl hemisuccinate"", ""start_span"": 66, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""tris salt"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""CS"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""carbon tetrachloride"", ""start_span"": 192, ""end_span"": 212, ""type"": ""Chemical/Drug""}, {""token"": ""CCl4"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	valid
The therapeutic use of selective DA D1 receptor agonists such as SKF - 82958 ( 6 - chloro - 7, 8 - dihydroxy - 3 - allyl - 1 - phenyl - 2, 3, 4, 5 - tetrahydro - 1H - 3 - benzaze pine hydrobromide) and A - 77636 ( [ 1R, 3S] 3 - [ 1 ' - admantyl] - 1 - aminomethyl - 3, 4 - dihydro - 5, 6 - dihydroxy - 1H - 2 - benzo pyran hydrochloride) seems limited because of their duration of action, which is too short for SKF - 82958 ( < 1 hr) and too long for A - 77636 ( > 20 hr, leading to behavioral tolerance).	DA,33,35,Chemical/Drug	SKF - 82958,65,76,Chemical/Drug	A - 77636,202,211,Chemical/Drug	SKF - 82958,412,423,Chemical/Drug	A - 77636,451,460,Chemical/Drug	"[{""token"": ""DA"", ""start_span"": 33, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""SKF - 82958"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""A - 77636"", ""start_span"": 202, ""end_span"": 211, ""type"": ""Chemical/Drug""}, {""token"": ""SKF - 82958"", ""start_span"": 412, ""end_span"": 423, ""type"": ""Chemical/Drug""}, {""token"": ""A - 77636"", ""start_span"": 451, ""end_span"": 460, ""type"": ""Chemical/Drug""}]"	valid
The effects of two unselective potassium ( K ( +) -) channel blockers, quinine ( 12. 5, 25 and 50 mg / kg) and 4 - aminopyridine ( 1 and 2 mg / kg), on conditioned place preference and biphasic changes in motor activity induced by morphine ( 10 mg / kg) were tested in Wistar rats.	potassium,31,40,Chemical/Drug	K,43,44,Chemical/Drug	quinine,71,78,Chemical/Drug	4 - aminopyridine,111,128,Chemical/Drug	morphine,231,239,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 31, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 43, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""quinine"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""4 - aminopyridine"", ""start_span"": 111, ""end_span"": 128, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 231, ""end_span"": 239, ""type"": ""Chemical/Drug""}]"	test
We propose that remoxipride and benzene may induce aplastic anemia via production of similar reactive metabolites and that the ability of NCQ436 and NCQ344 to induce apoptosis in HBMP cells may contribute to the mechanism underlying acquired aplastic anemia that has been associated with remoxipride.	remoxipride,16,27,Chemical/Drug	benzene,32,39,Chemical/Drug	NCQ436,138,144,Chemical/Drug	NCQ344,149,155,Chemical/Drug	remoxipride,288,299,Chemical/Drug	"[{""token"": ""remoxipride"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""benzene"", ""start_span"": 32, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""NCQ436"", ""start_span"": 138, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""NCQ344"", ""start_span"": 149, ""end_span"": 155, ""type"": ""Chemical/Drug""}, {""token"": ""remoxipride"", ""start_span"": 288, ""end_span"": 299, ""type"": ""Chemical/Drug""}]"	test
The participation of reactive oxygen species in aminoglycoside - induced ototoxicity has been deduced from observations that aminoglycoside - iron complexes catalyze the formation of superoxide radicals in vitro and that antioxidants attenuate ototoxicity in vivo.	oxygen,30,36,Chemical/Drug	aminoglycoside,48,62,Chemical/Drug	aminoglycoside,125,139,Chemical/Drug	iron,142,146,Chemical/Drug	superoxide,183,193,Chemical/Drug	"[{""token"": ""oxygen"", ""start_span"": 30, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""aminoglycoside"", ""start_span"": 48, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""aminoglycoside"", ""start_span"": 125, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""superoxide"", ""start_span"": 183, ""end_span"": 193, ""type"": ""Chemical/Drug""}]"	test
The aim of the present study was to determine the efficacy of glyceryl trinitrate ( GTN), an NO donor, in the resolution of primary dysmenorrhea in comparison with diclofenac ( DCF).	glyceryl trinitrate,62,81,Chemical/Drug	GTN,84,87,Chemical/Drug	NO,93,95,Chemical/Drug	diclofenac,164,174,Chemical/Drug	DCF,177,180,Chemical/Drug	"[{""token"": ""glyceryl trinitrate"", ""start_span"": 62, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""GTN"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 93, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""diclofenac"", ""start_span"": 164, ""end_span"": 174, ""type"": ""Chemical/Drug""}, {""token"": ""DCF"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Chemical/Drug""}]"	test
CPA reduced cocaine action at the doses which, given alone, did not influence motility, while CGS 21680 and NECA decreased the action of cocaine at the doses which, given alone, decreased locomotor activity in animals.	CPA,0,3,Chemical/Drug	cocaine,12,19,Chemical/Drug	CGS 21680,94,103,Chemical/Drug	NECA,108,112,Chemical/Drug	cocaine,137,144,Chemical/Drug	"[{""token"": ""CPA"", ""start_span"": 0, ""end_span"": 3, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 12, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""CGS 21680"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""NECA"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 137, ""end_span"": 144, ""type"": ""Chemical/Drug""}]"	test
The selective blockade of A2 adenosine receptors ( DMPX) and non - selective blockade of adenosine receptors ( caffeine) significantly increased the action of amphetamine in the locomotor activity test.	adenosine,29,38,Chemical/Drug	DMPX,51,55,Chemical/Drug	adenosine,89,98,Chemical/Drug	caffeine,111,119,Chemical/Drug	amphetamine,159,170,Chemical/Drug	"[{""token"": ""adenosine"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""DMPX"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""adenosine"", ""start_span"": 89, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""caffeine"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Chemical/Drug""}]"	test
Intracerebroventricular injection of ethacrynic acid ( 50% convulsive dose; 50 micrograms / mouse) accelerated the synthesis / turnover of 5 - hydroxytryptamine ( 5 - HT) but suppressed the synthesis of gamma - aminobutyric acid and acetylcholine in mouse brain.	ethacrynic acid,37,52,Chemical/Drug	5 - hydroxytryptamine,139,160,Chemical/Drug	5 - HT,163,169,Chemical/Drug	gamma - aminobutyric acid,203,228,Chemical/Drug	acetylcholine,233,246,Chemical/Drug	"[{""token"": ""ethacrynic acid"", ""start_span"": 37, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""5 - hydroxytryptamine"", ""start_span"": 139, ""end_span"": 160, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""gamma - aminobutyric acid"", ""start_span"": 203, ""end_span"": 228, ""type"": ""Chemical/Drug""}, {""token"": ""acetylcholine"", ""start_span"": 233, ""end_span"": 246, ""type"": ""Chemical/Drug""}]"	test
However, pretreatment with 5, 10 and 20 mg / kg i. p. trazodone enhanced dexamphetamine stereotypy, and antagonized haloperidol catalepsy, ergometrine - induced WDS behavior and fluoxetine - induced penile erections.	trazodone,54,63,Chemical/Drug	dexamphetamine,73,87,Chemical/Drug	haloperidol,116,127,Chemical/Drug	ergometrine,139,150,Chemical/Drug	fluoxetine,178,188,Chemical/Drug	"[{""token"": ""trazodone"", ""start_span"": 54, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""dexamphetamine"", ""start_span"": 73, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 116, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""ergometrine"", ""start_span"": 139, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""fluoxetine"", ""start_span"": 178, ""end_span"": 188, ""type"": ""Chemical/Drug""}]"	test
We suggest that trazodone ( 5, 10 and 20 mg / kg), by blocking the 5 - HT 2C receptors, releases the nigrostriatal DAergic neurons from tonic inhibition caused by 5 - HT, and thereby potentiates dexamphetamine stereotypy and antagonizes haloperidol catalepsy.	trazodone,16,25,Chemical/Drug	5 - HT,67,73,Chemical/Drug	5 - HT,163,169,Chemical/Drug	dexamphetamine,195,209,Chemical/Drug	haloperidol,237,248,Chemical/Drug	"[{""token"": ""trazodone"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 67, ""end_span"": 73, ""type"": ""Chemical/Drug""}, {""token"": ""5 - HT"", ""start_span"": 163, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""dexamphetamine"", ""start_span"": 195, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 237, ""end_span"": 248, ""type"": ""Chemical/Drug""}]"	test
BACKGROUND: Acetaminophen ( paracetamol - - P) and Nimesulide ( N) are widely used analgesic - antipyretic / anti - inflammatory drugs.	Acetaminophen,12,25,Chemical/Drug	paracetamol,28,39,Chemical/Drug	P,44,45,Chemical/Drug	Nimesulide,51,61,Chemical/Drug	N,64,65,Chemical/Drug	"[{""token"": ""Acetaminophen"", ""start_span"": 12, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""paracetamol"", ""start_span"": 28, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""P"", ""start_span"": 44, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""Nimesulide"", ""start_span"": 51, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""N"", ""start_span"": 64, ""end_span"": 65, ""type"": ""Chemical/Drug""}]"	test
The aims of this study were to examine vancomycin ( VCM) - induced oxidative stress that promotes production of reactive oxygen species ( ROS) and to investigate the role of erdosteine, an expectorant agent, which has also antioxidant properties, on kidney tissue against the possible VCM - induced renal impairment in rats.	vancomycin,39,49,Chemical/Drug	VCM,52,55,Chemical/Drug	oxygen,121,127,Chemical/Drug	erdosteine,174,184,Chemical/Drug	VCM,285,288,Chemical/Drug	"[{""token"": ""vancomycin"", ""start_span"": 39, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""VCM"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 121, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""erdosteine"", ""start_span"": 174, ""end_span"": 184, ""type"": ""Chemical/Drug""}, {""token"": ""VCM"", ""start_span"": 285, ""end_span"": 288, ""type"": ""Chemical/Drug""}]"	test
With 2 - drug therapy, mean total cholesterol decreased 22% from 255 to 200 mg / dl, triglyceride levels decreased 35% from 236 to 154 mg / dl, LDL cholesterol decreased 26% from 176 to 131 mg / dl, and the total cholesterol / HDL cholesterol ratio decreased 24% from 7. 1 to 5. 4, all p less than or equal to 0. 0001.	cholesterol,34,45,Chemical/Drug	triglyceride,85,97,Chemical/Drug	cholesterol,148,159,Chemical/Drug	cholesterol,213,224,Chemical/Drug	cholesterol,231,242,Chemical/Drug	"[{""token"": ""cholesterol"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""triglyceride"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 148, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 213, ""end_span"": 224, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 231, ""end_span"": 242, ""type"": ""Chemical/Drug""}]"	test
The semisynthetic flavonoid monohydroxyethylrutoside ( monoHER) showed cardioprotection against DOX - induced cardiotoxicity through its radical scavenging and iron chelating properties.	flavonoid,18,27,Chemical/Drug	monohydroxyethylrutoside,28,52,Chemical/Drug	monoHER,55,62,Chemical/Drug	DOX,96,99,Chemical/Drug	iron,160,164,Chemical/Drug	"[{""token"": ""flavonoid"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""monohydroxyethylrutoside"", ""start_span"": 28, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""monoHER"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""DOX"", ""start_span"": 96, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Chemical/Drug""}]"	test
Chloroacetaldehyde ( CAA) is a metabolite of the alkylating agent ifosfamide ( IFO) and putatively responsible for renal damage following anti - tumor therapy with IFO.	Chloroacetaldehyde,0,18,Chemical/Drug	CAA,21,24,Chemical/Drug	ifosfamide,66,76,Chemical/Drug	IFO,79,82,Chemical/Drug	IFO,164,167,Chemical/Drug	"[{""token"": ""Chloroacetaldehyde"", ""start_span"": 0, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""CAA"", ""start_span"": 21, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""ifosfamide"", ""start_span"": 66, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""IFO"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""IFO"", ""start_span"": 164, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	test
Acidification, which slowed the reaction of CAA with thiol donors, could also attenuate effects of CAA on necrosis markers, thiol depletion and cysteine protease inhibition in living cells.	CAA,44,47,Chemical/Drug	thiol,53,58,Chemical/Drug	CAA,99,102,Chemical/Drug	thiol,124,129,Chemical/Drug	cysteine,144,152,Chemical/Drug	"[{""token"": ""CAA"", ""start_span"": 44, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""thiol"", ""start_span"": 53, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""CAA"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""thiol"", ""start_span"": 124, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""cysteine"", ""start_span"": 144, ""end_span"": 152, ""type"": ""Chemical/Drug""}]"	test
The metabolic responses to isoprenaline in dogs ( an increase in circulating glucose, lactate and free fatty acids) were all blocked by ( -) - propranolol.	isoprenaline,27,39,Chemical/Drug	glucose,77,84,Chemical/Drug	lactate,86,93,Chemical/Drug	fatty acids,103,114,Chemical/Drug	propranolol,143,154,Chemical/Drug	"[{""token"": ""isoprenaline"", ""start_span"": 27, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 77, ""end_span"": 84, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""fatty acids"", ""start_span"": 103, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical/Drug""}]"	test
Both isomers of propranolol were capable of preventing adrenaline - induced cardiac arrhythmias in cats anaesthetized with halothane, but the mean dose of ( -) - propranolol was 0. 09 + / - 0. 02 mg / kg whereas that of ( +) - propranolol was 4. 2 + / - 1. 2 mg / kg.	propranolol,16,27,Chemical/Drug	adrenaline,55,65,Chemical/Drug	halothane,123,132,Chemical/Drug	propranolol,162,173,Chemical/Drug	propranolol,227,238,Chemical/Drug	"[{""token"": ""propranolol"", ""start_span"": 16, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""adrenaline"", ""start_span"": 55, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""halothane"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 162, ""end_span"": 173, ""type"": ""Chemical/Drug""}, {""token"": ""propranolol"", ""start_span"": 227, ""end_span"": 238, ""type"": ""Chemical/Drug""}]"	test
DESIGN: Dose response curves for nonsedating doses of morphine and CNSB002 given intraperitoneally alone and together in combinations were constructed for antihyperalgesic effect using paw withdrawal from noxious heat in two rat pain models: carrageenan - induced paw inflammation and streptozotocin ( STZ) - induced diabetic neuropathy.	morphine,54,62,Chemical/Drug	CNSB002,67,74,Chemical/Drug	carrageenan,242,253,Chemical/Drug	streptozotocin,285,299,Chemical/Drug	STZ,302,305,Chemical/Drug	"[{""token"": ""morphine"", ""start_span"": 54, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""CNSB002"", ""start_span"": 67, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""carrageenan"", ""start_span"": 242, ""end_span"": 253, ""type"": ""Chemical/Drug""}, {""token"": ""streptozotocin"", ""start_span"": 285, ""end_span"": 299, ""type"": ""Chemical/Drug""}, {""token"": ""STZ"", ""start_span"": 302, ""end_span"": 305, ""type"": ""Chemical/Drug""}]"	test
Nitric oxide ( NO), gaseous neurotransmitter, has contradictor role in epileptogenesis due to opposite effects of L - arginine, precursor of NO syntheses ( NOS), and L - NAME ( NOS inhibitor) observed in different epilepsy models.	Nitric oxide,0,12,Chemical/Drug	NO,15,17,Chemical/Drug	L - arginine,114,126,Chemical/Drug	NO,141,143,Chemical/Drug	L - NAME,166,174,Chemical/Drug	"[{""token"": ""Nitric oxide"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 15, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""L - arginine"", ""start_span"": 114, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 141, ""end_span"": 143, ""type"": ""Chemical/Drug""}, {""token"": ""L - NAME"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Chemical/Drug""}]"	test
The aim of this study is to investigate and compare the protective effects of isotonic sodium chloride with sodium bicarbonate infusion and isotonic sodium chloride infusion with diltiazem, a calcium channel blocker, in preventing CIN.	sodium chloride,87,102,Chemical/Drug	sodium bicarbonate,108,126,Chemical/Drug	sodium chloride,149,164,Chemical/Drug	diltiazem,179,188,Chemical/Drug	calcium,192,199,Chemical/Drug	"[{""token"": ""sodium chloride"", ""start_span"": 87, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""sodium bicarbonate"", ""start_span"": 108, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""sodium chloride"", ""start_span"": 149, ""end_span"": 164, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 179, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 192, ""end_span"": 199, ""type"": ""Chemical/Drug""}]"	test
The first group of patients was administered isotonic sodium chloride; the second group was administered a solution that of 5% dextrose and sodium bicarbonate, while the third group was administered isotonic sodium chloride before and after the contrast injection.	sodium chloride,54,69,Chemical/Drug	dextrose,127,135,Chemical/Drug	sodium bicarbonate,140,158,Chemical/Drug	sodium chloride,208,223,Chemical/Drug	contrast,245,253,Chemical/Drug	"[{""token"": ""sodium chloride"", ""start_span"": 54, ""end_span"": 69, ""type"": ""Chemical/Drug""}, {""token"": ""dextrose"", ""start_span"": 127, ""end_span"": 135, ""type"": ""Chemical/Drug""}, {""token"": ""sodium bicarbonate"", ""start_span"": 140, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""sodium chloride"", ""start_span"": 208, ""end_span"": 223, ""type"": ""Chemical/Drug""}, {""token"": ""contrast"", ""start_span"": 245, ""end_span"": 253, ""type"": ""Chemical/Drug""}]"	test
BACKGROUND: In this retrospective comparative study, we aimed to compare the effectiveness of fentanyl, midazolam, and a combination of fentanyl and midazolam to prevent etomidate - induced myoclonus.	fentanyl,94,102,Chemical/Drug	midazolam,104,113,Chemical/Drug	fentanyl,136,144,Chemical/Drug	midazolam,149,158,Chemical/Drug	etomidate,170,179,Chemical/Drug	"[{""token"": ""fentanyl"", ""start_span"": 94, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""midazolam"", ""start_span"": 104, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""midazolam"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""etomidate"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	test
Depending on the drugs that would be given before the induction of anesthesia with etomidate, the patients were separated into 4 groups: no pretreatment ( Group NP), fentanyl 1 ug. kg - 1 ( Group F), midazolam 0. 03 mg. kg - 1 ( Group M), and midazolam 0. 015 mg. kg - 1 + fentanyl 0. 5 ug. kg - 1 ( Group FM).	etomidate,83,92,Chemical/Drug	fentanyl,166,174,Chemical/Drug	midazolam,200,209,Chemical/Drug	midazolam,243,252,Chemical/Drug	fentanyl,273,281,Chemical/Drug	"[{""token"": ""etomidate"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 166, ""end_span"": 174, ""type"": ""Chemical/Drug""}, {""token"": ""midazolam"", ""start_span"": 200, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""midazolam"", ""start_span"": 243, ""end_span"": 252, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 273, ""end_span"": 281, ""type"": ""Chemical/Drug""}]"	test
Administration of flutamide, letrozole or tamoxifen significantly impaired the memory in intact rats, and significantly attenuated the testosterone replacement in improving STZ - and castration - induced memory impairment.	flutamide,18,27,Chemical/Drug	letrozole,29,38,Chemical/Drug	tamoxifen,42,51,Chemical/Drug	testosterone,135,147,Chemical/Drug	STZ,173,176,Chemical/Drug	"[{""token"": ""flutamide"", ""start_span"": 18, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""letrozole"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""tamoxifen"", ""start_span"": 42, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""testosterone"", ""start_span"": 135, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""STZ"", ""start_span"": 173, ""end_span"": 176, ""type"": ""Chemical/Drug""}]"	test
Protocols of conversion from cyclosporin A ( CsA) to sirolimus ( SRL) have been widely used in immunotherapy after transplantation to prevent CsA - induced nephropathy, but the molecular mechanisms underlying these protocols remain nuclear.	cyclosporin A,29,42,Chemical/Drug	CsA,45,48,Chemical/Drug	sirolimus,53,62,Chemical/Drug	SRL,65,68,Chemical/Drug	CsA,142,145,Chemical/Drug	"[{""token"": ""cyclosporin A"", ""start_span"": 29, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""sirolimus"", ""start_span"": 53, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 142, ""end_span"": 145, ""type"": ""Chemical/Drug""}]"	test
Urinary sodium, potassium and calcium were elevated in lithium - fed WT but not in lithium - fed PKCa KO mice.	sodium,8,14,Chemical/Drug	potassium,16,25,Chemical/Drug	calcium,30,37,Chemical/Drug	lithium,55,62,Chemical/Drug	lithium,83,90,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 8, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 16, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 30, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 55, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Chemical/Drug""}]"	test
Low activity of patient plasma butyrylcholinesterase with butyrylthiocholine ( BTC) and benzoylcholine, and values of dibucaine and fluoride numbers fit with heterozygous atypical silent genotype.	butyrylthiocholine,58,76,Chemical/Drug	BTC,79,82,Chemical/Drug	benzoylcholine,88,102,Chemical/Drug	dibucaine,118,127,Chemical/Drug	fluoride,132,140,Chemical/Drug	"[{""token"": ""butyrylthiocholine"", ""start_span"": 58, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""BTC"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""benzoylcholine"", ""start_span"": 88, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""dibucaine"", ""start_span"": 118, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""fluoride"", ""start_span"": 132, ""end_span"": 140, ""type"": ""Chemical/Drug""}]"	test
In addition, maleate treatment reduced oxygen consumption in ADP - stimulated mitochondria and diminished respiratory control index when using malate / glutamate as substrate.	maleate,13,20,Chemical/Drug	oxygen,39,45,Chemical/Drug	ADP,61,64,Chemical/Drug	malate,143,149,Chemical/Drug	glutamate,152,161,Chemical/Drug	"[{""token"": ""maleate"", ""start_span"": 13, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 39, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""ADP"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""malate"", ""start_span"": 143, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 152, ""end_span"": 161, ""type"": ""Chemical/Drug""}]"	test
Pretreatment of animals with BNPP prior to APAP or PAP administration resulted in marked reduction of APAP ( 900 mg / kg) nephrotoxicity but not PAP nephrotoxicity.	BNPP,29,33,Chemical/Drug	APAP,43,47,Chemical/Drug	PAP,51,54,Chemical/Drug	APAP,102,106,Chemical/Drug	PAP,145,148,Chemical/Drug	"[{""token"": ""BNPP"", ""start_span"": 29, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""APAP"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""PAP"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""APAP"", ""start_span"": 102, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""PAP"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Chemical/Drug""}]"	test
BNPP did not alter the excretion of APAP or any of its non - deacetylated metabolites nor did BNPP alter excretion of PAP or its metabolites after PAP doses of 150 and 300 mg / kg.	BNPP,0,4,Chemical/Drug	APAP,36,40,Chemical/Drug	BNPP,94,98,Chemical/Drug	PAP,118,121,Chemical/Drug	PAP,147,150,Chemical/Drug	"[{""token"": ""BNPP"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Chemical/Drug""}, {""token"": ""APAP"", ""start_span"": 36, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""BNPP"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""PAP"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""PAP"", ""start_span"": 147, ""end_span"": 150, ""type"": ""Chemical/Drug""}]"	test
Four types of experimental arrhythmia are used - - with BaCl2, with chloroform - adrenaline, with strophantine G and with aconitine.	BaCl2,56,61,Chemical/Drug	chloroform,68,78,Chemical/Drug	adrenaline,81,91,Chemical/Drug	strophantine G,98,112,Chemical/Drug	aconitine,122,131,Chemical/Drug	"[{""token"": ""BaCl2"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""chloroform"", ""start_span"": 68, ""end_span"": 78, ""type"": ""Chemical/Drug""}, {""token"": ""adrenaline"", ""start_span"": 81, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""strophantine G"", ""start_span"": 98, ""end_span"": 112, ""type"": ""Chemical/Drug""}, {""token"": ""aconitine"", ""start_span"": 122, ""end_span"": 131, ""type"": ""Chemical/Drug""}]"	test
An interaction between FZP and pentylenetetrazol ( PTZ) was shown by pretreating mice with FZP before PTZ challenge.	FZP,23,26,Chemical/Drug	pentylenetetrazol,31,48,Chemical/Drug	PTZ,51,54,Chemical/Drug	FZP,91,94,Chemical/Drug	PTZ,102,105,Chemical/Drug	"[{""token"": ""FZP"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazol"", ""start_span"": 31, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""PTZ"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Chemical/Drug""}, {""token"": ""FZP"", ""start_span"": 91, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""PTZ"", ""start_span"": 102, ""end_span"": 105, ""type"": ""Chemical/Drug""}]"	test
Seventeen renal patients received azathioprine ( Aza) and prednisone as part of a randomized trial of immunosuppression with 21 cyclosporine - and - prednisone - treated renal transplant patients.	azathioprine,34,46,Chemical/Drug	Aza,49,52,Chemical/Drug	prednisone,58,68,Chemical/Drug	cyclosporine,128,140,Chemical/Drug	prednisone,149,159,Chemical/Drug	"[{""token"": ""azathioprine"", ""start_span"": 34, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""Aza"", ""start_span"": 49, ""end_span"": 52, ""type"": ""Chemical/Drug""}, {""token"": ""prednisone"", ""start_span"": 58, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""cyclosporine"", ""start_span"": 128, ""end_span"": 140, ""type"": ""Chemical/Drug""}, {""token"": ""prednisone"", ""start_span"": 149, ""end_span"": 159, ""type"": ""Chemical/Drug""}]"	test
Intraperitoneal administration of cholecystokinin octapeptide sulphate ester ( CCK - 8 - SE) and nonsulphated cholecystokinin octapeptide ( CCK - 8 - NS) enhanced the latency of seizures induced by picrotoxin in mice.	cholecystokinin octapeptide,34,61,Chemical/Drug	CCK - 8,79,86,Chemical/Drug	cholecystokinin octapeptide,110,137,Chemical/Drug	CCK - 8,140,147,Chemical/Drug	picrotoxin,198,208,Chemical/Drug	"[{""token"": ""cholecystokinin octapeptide"", ""start_span"": 34, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""CCK - 8"", ""start_span"": 79, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""cholecystokinin octapeptide"", ""start_span"": 110, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""CCK - 8"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 198, ""end_span"": 208, ""type"": ""Chemical/Drug""}]"	test
The reduction of amphetamine hyperactivity induced by DSP4 was blocked by pretreatment with the noradrenaline - uptake blocking agent, desipramine, which prevents the neurotoxic action of DSP4.	amphetamine,17,28,Chemical/Drug	DSP4,54,58,Chemical/Drug	noradrenaline,96,109,Chemical/Drug	desipramine,135,146,Chemical/Drug	DSP4,188,192,Chemical/Drug	"[{""token"": ""amphetamine"", ""start_span"": 17, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""DSP4"", ""start_span"": 54, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""noradrenaline"", ""start_span"": 96, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 135, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""DSP4"", ""start_span"": 188, ""end_span"": 192, ""type"": ""Chemical/Drug""}]"	test
An 11 - year - old boy was given halothane, nitrous oxide and oxygen, pancuronium 0. 4 mg and suxamethonium 100 mg for induction of anaesthesia.	halothane,33,42,Chemical/Drug	nitrous oxide,44,57,Chemical/Drug	oxygen,62,68,Chemical/Drug	pancuronium,70,81,Chemical/Drug	suxamethonium,94,107,Chemical/Drug	"[{""token"": ""halothane"", ""start_span"": 33, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""nitrous oxide"", ""start_span"": 44, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 62, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""pancuronium"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""suxamethonium"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	test
S - 312, S - 312 - d, but not S - 312 - l, L - type calcium channel antagonists, showed anticonvulsant effects on the audiogenic tonic convulsions in DBA / 2 mice; and their ED50 values were 18. 4 ( 12. 8 - 27. 1) mg / kg, p. o. and 15. 0 ( 10. 2 - 23. 7) mg / kg, p. o., respectively, while that of flunarizine was 34. 0 ( 26. 0 - 44. 8) mg / kg, p. o.	S - 312,0,7,Chemical/Drug	S - 312 - d,9,20,Chemical/Drug	S - 312 - l,30,41,Chemical/Drug	calcium,52,59,Chemical/Drug	flunarizine,300,311,Chemical/Drug	"[{""token"": ""S - 312"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Chemical/Drug""}, {""token"": ""S - 312 - d"", ""start_span"": 9, ""end_span"": 20, ""type"": ""Chemical/Drug""}, {""token"": ""S - 312 - l"", ""start_span"": 30, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 52, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""flunarizine"", ""start_span"": 300, ""end_span"": 311, ""type"": ""Chemical/Drug""}]"	test
Although moderate anticonvulsant effects of S - 312 - d in higher doses were observed against the clonic convulsions induced by pentylenetetrazole ( 85 mg / kg, s. c.) or bemegride ( 40 mg / kg, s. c.), no effects were observed in convulsions induced by N - methyl - D - aspartate, picrotoxin, or electroshock in Slc: ddY mice.	S - 312 - d,44,55,Chemical/Drug	pentylenetetrazole,128,146,Chemical/Drug	bemegride,171,180,Chemical/Drug	N - methyl - D - aspartate,254,280,Chemical/Drug	picrotoxin,282,292,Chemical/Drug	"[{""token"": ""S - 312 - d"", ""start_span"": 44, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazole"", ""start_span"": 128, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""bemegride"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""N - methyl - D - aspartate"", ""start_span"": 254, ""end_span"": 280, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 282, ""end_span"": 292, ""type"": ""Chemical/Drug""}]"	test
These results suggest that 1) both SOD and DMTU have protective effects on GM - mediated nephropathy, 2) the mechanisms for the protective effects differ for SOD and DMTU, and 3) superoxide anions play a critical role in GM - induced renal vasoconstriction.	DMTU,43,47,Chemical/Drug	GM,75,77,Chemical/Drug	DMTU,166,170,Chemical/Drug	superoxide,179,189,Chemical/Drug	GM,221,223,Chemical/Drug	"[{""token"": ""DMTU"", ""start_span"": 43, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""GM"", ""start_span"": 75, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""DMTU"", ""start_span"": 166, ""end_span"": 170, ""type"": ""Chemical/Drug""}, {""token"": ""superoxide"", ""start_span"": 179, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""GM"", ""start_span"": 221, ""end_span"": 223, ""type"": ""Chemical/Drug""}]"	test
Left atrial and left ventricular papillary muscle contractile responses to isoproterenol were reduced compared to controls in groups treated with clentiazem alone, but combined with epinephrine, clentiazem restored left atrial responses and enhanced left ventricular papillary responses to isoproterenol.	isoproterenol,75,88,Chemical/Drug	clentiazem,146,156,Chemical/Drug	epinephrine,182,193,Chemical/Drug	clentiazem,195,205,Chemical/Drug	isoproterenol,290,303,Chemical/Drug	"[{""token"": ""isoproterenol"", ""start_span"": 75, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""clentiazem"", ""start_span"": 146, ""end_span"": 156, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 182, ""end_span"": 193, ""type"": ""Chemical/Drug""}, {""token"": ""clentiazem"", ""start_span"": 195, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""isoproterenol"", ""start_span"": 290, ""end_span"": 303, ""type"": ""Chemical/Drug""}]"	test
Effects of CD - 832 on isoproterenol ( ISO) - induced myocardial ischemia were studied in dogs with partial coronary stenosis of the left circumflex coronary artery and findings were compared with those for nifedipine or diltiazem.	CD - 832,11,19,Chemical/Drug	isoproterenol,23,36,Chemical/Drug	ISO,39,42,Chemical/Drug	nifedipine,207,217,Chemical/Drug	diltiazem,221,230,Chemical/Drug	"[{""token"": ""CD - 832"", ""start_span"": 11, ""end_span"": 19, ""type"": ""Chemical/Drug""}, {""token"": ""isoproterenol"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""ISO"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""nifedipine"", ""start_span"": 207, ""end_span"": 217, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 221, ""end_span"": 230, ""type"": ""Chemical/Drug""}]"	test
After the control ISO infusion with stenosis was performed, equihypotensive doses of CD - 832 ( 3 and 10 micrograms / kg / min, n = 7), nifedipine ( 1 and 3 micrograms / kg / min, n = 9) or diltiazem ( 10 and 30 micrograms / kg / min, n = 7) were infused 5 min before and during the second and third ISO infusion.	ISO,18,21,Chemical/Drug	CD - 832,85,93,Chemical/Drug	nifedipine,136,146,Chemical/Drug	diltiazem,190,199,Chemical/Drug	ISO,300,303,Chemical/Drug	"[{""token"": ""ISO"", ""start_span"": 18, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""CD - 832"", ""start_span"": 85, ""end_span"": 93, ""type"": ""Chemical/Drug""}, {""token"": ""nifedipine"", ""start_span"": 136, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 190, ""end_span"": 199, ""type"": ""Chemical/Drug""}, {""token"": ""ISO"", ""start_span"": 300, ""end_span"": 303, ""type"": ""Chemical/Drug""}]"	test
Scopolamine and pentobarbital blocked the pilocarpine - induced electrographic seizure, MK - 801 treatment augmented the electrographic seizure induced by pilocarpine.	Scopolamine,0,11,Chemical/Drug	pentobarbital,16,29,Chemical/Drug	pilocarpine,42,53,Chemical/Drug	MK - 801,88,96,Chemical/Drug	pilocarpine,155,166,Chemical/Drug	"[{""token"": ""Scopolamine"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""pentobarbital"", ""start_span"": 16, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 42, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 88, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 155, ""end_span"": 166, ""type"": ""Chemical/Drug""}]"	test
Pentobarbital, scopolamine and MK - 801 protected the brain damage by pilocarpine, though in the MK - 801 - treated group, the pyramidal cells of hippocampus appeared darker than normal.	Pentobarbital,0,13,Chemical/Drug	scopolamine,15,26,Chemical/Drug	MK - 801,31,39,Chemical/Drug	pilocarpine,70,81,Chemical/Drug	MK - 801,97,105,Chemical/Drug	"[{""token"": ""Pentobarbital"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 15, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 31, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 70, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""MK - 801"", ""start_span"": 97, ""end_span"": 105, ""type"": ""Chemical/Drug""}]"	test
On the other hand, the pressor response to i. c. carbachol ( 1 mug) was almost completely blocked by i. c. atropine ( 3 mug) or hexamethonium ( 500 mug), and significantly reduced by i. c. chlorpromazine ( 50 mug) but significantly potentiated by i. c. desmethylimipramine ( 30 mug).	carbachol,49,58,Chemical/Drug	atropine,107,115,Chemical/Drug	hexamethonium,128,141,Chemical/Drug	chlorpromazine,189,203,Chemical/Drug	desmethylimipramine,253,272,Chemical/Drug	"[{""token"": ""carbachol"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""hexamethonium"", ""start_span"": 128, ""end_span"": 141, ""type"": ""Chemical/Drug""}, {""token"": ""chlorpromazine"", ""start_span"": 189, ""end_span"": 203, ""type"": ""Chemical/Drug""}, {""token"": ""desmethylimipramine"", ""start_span"": 253, ""end_span"": 272, ""type"": ""Chemical/Drug""}]"	test
Effects of 17alpha - ethinylestradiol ( EE) on the neutral and acidic biosynthetic pathways of bile salt ( BS) synthesis were evaluated in rats with an intact enterohepatic circulation and in rats with long - term bile diversion to induce BS synthesis.	17alpha - ethinylestradiol,11,37,Chemical/Drug	EE,40,42,Chemical/Drug	bile salt,95,104,Chemical/Drug	BS,107,109,Chemical/Drug	BS,239,241,Chemical/Drug	"[{""token"": ""17alpha - ethinylestradiol"", ""start_span"": 11, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""EE"", ""start_span"": 40, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""bile salt"", ""start_span"": 95, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""BS"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""BS"", ""start_span"": 239, ""end_span"": 241, ""type"": ""Chemical/Drug""}]"	test
These findings suggest that helodermin - produced hypotension is partly attributable to the activation of glibenclamide - sensitive K + channels ( K ( ATP) channels), which presumably exist on arterial smooth muscle cells.	helodermin,28,38,Chemical/Drug	glibenclamide,106,119,Chemical/Drug	K,132,133,Chemical/Drug	K,147,148,Chemical/Drug	ATP,151,154,Chemical/Drug	"[{""token"": ""helodermin"", ""start_span"": 28, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""glibenclamide"", ""start_span"": 106, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 132, ""end_span"": 133, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 147, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 151, ""end_span"": 154, ""type"": ""Chemical/Drug""}]"	test
Tetrandrine ( TET) and fangchinoline ( FAN) are two naturally occurring analogues with a bisbenzylisoquinoline structure.	Tetrandrine,0,11,Chemical/Drug	TET,14,17,Chemical/Drug	fangchinoline,23,36,Chemical/Drug	FAN,39,42,Chemical/Drug	bisbenzylisoquinoline,89,110,Chemical/Drug	"[{""token"": ""Tetrandrine"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Chemical/Drug""}, {""token"": ""TET"", ""start_span"": 14, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""fangchinoline"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""FAN"", ""start_span"": 39, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""bisbenzylisoquinoline"", ""start_span"": 89, ""end_span"": 110, ""type"": ""Chemical/Drug""}]"	train
There was a close parallel between the effect of vitamin D dose on artery calcification and the effect of vitamin D dose on the elevation of serum calcium, which suggests that vitamin D may induce artery calcification through its effect on serum calcium.	vitamin D,49,58,Chemical/Drug	vitamin D,106,115,Chemical/Drug	calcium,147,154,Chemical/Drug	vitamin D,176,185,Chemical/Drug	calcium,246,253,Chemical/Drug	"[{""token"": ""vitamin D"", ""start_span"": 49, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin D"", ""start_span"": 106, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 147, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin D"", ""start_span"": 176, ""end_span"": 185, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Chemical/Drug""}]"	train
Dopamine turnover ratios ( DOPAC: DA and HVA: DA) were found to be lower in those animals exposed to the exploratory box when compared to their home cage counterparts.	Dopamine,0,8,Chemical/Drug	DOPAC,27,32,Chemical/Drug	DA,34,36,Chemical/Drug	HVA,41,44,Chemical/Drug	DA,46,48,Chemical/Drug	"[{""token"": ""Dopamine"", ""start_span"": 0, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""DOPAC"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 34, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""HVA"", ""start_span"": 41, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 46, ""end_span"": 48, ""type"": ""Chemical/Drug""}]"	train
Changes of sodium and ATP affinities of the cardiac ( Na, K) - ATPase during and after nitric oxide deficient hypertension.	sodium,11,17,Chemical/Drug	ATP,22,25,Chemical/Drug	Na,54,56,Chemical/Drug	K,58,59,Chemical/Drug	nitric oxide,87,99,Chemical/Drug	"[{""token"": ""sodium"", ""start_span"": 11, ""end_span"": 17, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 22, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 54, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 58, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""nitric oxide"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Chemical/Drug""}]"	train
During activation with Na +, the Vmax remained unchanged, however the K ( Na) increased by 50%, indicating a profound decrease in the affinity of the Na + - binding site in NO - deficient rats.	Na,23,25,Chemical/Drug	K,70,71,Chemical/Drug	Na,74,76,Chemical/Drug	Na,150,152,Chemical/Drug	NO,173,175,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 23, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 70, ""end_span"": 71, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 74, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 150, ""end_span"": 152, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 173, ""end_span"": 175, ""type"": ""Chemical/Drug""}]"	train
Inhibition of NO - synthase induced a reversible hypertension accompanied by depressed Na + - extrusion from cardiac cells as a consequence of deteriorated Na + - binding properties of the ( Na, K) - ATPase.	NO,14,16,Chemical/Drug	Na,87,89,Chemical/Drug	Na,156,158,Chemical/Drug	Na,191,193,Chemical/Drug	K,195,196,Chemical/Drug	"[{""token"": ""NO"", ""start_span"": 14, ""end_span"": 16, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 87, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 156, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 191, ""end_span"": 193, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 195, ""end_span"": 196, ""type"": ""Chemical/Drug""}]"	train
Results presented here show that the differential sensitivities of BS and BR lines to beta - CCM can be extended to diazepam, picrotoxin, and pentylenetetrazol, suggesting a genetic selection of a general sensitivity and resistance to several ligands of the GABA ( A) receptor.	beta - CCM,86,96,Chemical/Drug	diazepam,116,124,Chemical/Drug	picrotoxin,126,136,Chemical/Drug	pentylenetetrazol,142,159,Chemical/Drug	GABA,258,262,Chemical/Drug	"[{""token"": ""beta - CCM"", ""start_span"": 86, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""pentylenetetrazol"", ""start_span"": 142, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 258, ""end_span"": 262, ""type"": ""Chemical/Drug""}]"	train
Patients who experienced a manic or hypomanic switch were compared with those who did not on several variables including age, sex, diagnosis ( DSM - IV bipolar I vs. bipolar II), number of previous manic episodes, type of antidepressant therapy used ( electroconvulsive therapy vs. antidepressant drugs and, more particularly, selective serotonin reuptake inhibitors [ SSRIs]), use and type of mood stabilizers ( lithium vs. anticonvulsants), and temperament of the patient, assessed during a normothymic period using the hyperthymia component of the Semi - structured Affective Temperament Interview.	antidepressant,222,236,Chemical/Drug	antidepressant,282,296,Chemical/Drug	serotonin reuptake inhibitors,337,366,Chemical/Drug	SSRIs,369,374,Chemical/Drug	lithium,413,420,Chemical/Drug	"[{""token"": ""antidepressant"", ""start_span"": 222, ""end_span"": 236, ""type"": ""Chemical/Drug""}, {""token"": ""antidepressant"", ""start_span"": 282, ""end_span"": 296, ""type"": ""Chemical/Drug""}, {""token"": ""serotonin reuptake inhibitors"", ""start_span"": 337, ""end_span"": 366, ""type"": ""Chemical/Drug""}, {""token"": ""SSRIs"", ""start_span"": 369, ""end_span"": 374, ""type"": ""Chemical/Drug""}, {""token"": ""lithium"", ""start_span"": 413, ""end_span"": 420, ""type"": ""Chemical/Drug""}]"	train
The aim of this study was to examine further the renal function, including morphological analysis of the kidneys of male Sprague - Dawley rats treated with either cyclosporine A ( CsA), tacrolimus ( FK506) or SRL as monotherapies or in different combinations.	cyclosporine A,163,177,Chemical/Drug	CsA,180,183,Chemical/Drug	tacrolimus,186,196,Chemical/Drug	FK506,199,204,Chemical/Drug	SRL,209,212,Chemical/Drug	"[{""token"": ""cyclosporine A"", ""start_span"": 163, ""end_span"": 177, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 180, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""tacrolimus"", ""start_span"": 186, ""end_span"": 196, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 199, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 209, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	train
A further deterioration was seen when CsA was combined with either FK506 or SRL, whereas the GFR remained unchanged in the group treated with FK506 plus SRL when compared with treatment with any of the single substances.	CsA,38,41,Chemical/Drug	FK506,67,72,Chemical/Drug	SRL,76,79,Chemical/Drug	FK506,142,147,Chemical/Drug	SRL,153,156,Chemical/Drug	"[{""token"": ""CsA"", ""start_span"": 38, ""end_span"": 41, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""FK506"", ""start_span"": 142, ""end_span"": 147, ""type"": ""Chemical/Drug""}, {""token"": ""SRL"", ""start_span"": 153, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	train
A single MPEP ( 5 mg / kg ip) injection reduced the basal extracellular dopamine level in the striatum, as well as dopamine release stimulated either by methamphetamine ( 10 mg / kg sc) or by intrastriatally administered veratridine ( 100 microM).	MPEP,9,13,Chemical/Drug	dopamine,72,80,Chemical/Drug	dopamine,115,123,Chemical/Drug	methamphetamine,153,168,Chemical/Drug	veratridine,221,232,Chemical/Drug	"[{""token"": ""MPEP"", ""start_span"": 9, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 72, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 115, ""end_span"": 123, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 153, ""end_span"": 168, ""type"": ""Chemical/Drug""}, {""token"": ""veratridine"", ""start_span"": 221, ""end_span"": 232, ""type"": ""Chemical/Drug""}]"	train
The present study was designed to evaluate two endogenous and one synthetic neuroactive steroid that positively modulate the gamma - aminobutyric acid ( GABA ( A)) receptor against the increase in sensitivity to the convulsant effects of cocaine engendered by repeated cocaine administration ( seizure kindling).	steroid,88,95,Chemical/Drug	gamma - aminobutyric acid,125,150,Chemical/Drug	GABA,153,157,Chemical/Drug	cocaine,238,245,Chemical/Drug	cocaine,269,276,Chemical/Drug	"[{""token"": ""steroid"", ""start_span"": 88, ""end_span"": 95, ""type"": ""Chemical/Drug""}, {""token"": ""gamma - aminobutyric acid"", ""start_span"": 125, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 153, ""end_span"": 157, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 238, ""end_span"": 245, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 269, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	train
Depletion of dopamine in the striatum was also antagonized when LY274614 was given after the injection of amphetamine; LY274614 protected when given up to 4 hr after but not when given 8 or 24 hr after amphetamine.	dopamine,13,21,Chemical/Drug	LY274614,64,72,Chemical/Drug	amphetamine,106,117,Chemical/Drug	LY274614,119,127,Chemical/Drug	amphetamine,202,213,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 13, ""end_span"": 21, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 64, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 106, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""amphetamine"", ""start_span"": 202, ""end_span"": 213, ""type"": ""Chemical/Drug""}]"	train
The data strengthen the evidence that the neurotoxic effect of amphetamine and related compounds toward nigrostriatal dopamine neurons involves NMDA receptors and that LY274614 is an NMDA receptor antagonist with long - lasting in vivo effects in rats.	amphetamine,63,74,Chemical/Drug	dopamine,118,126,Chemical/Drug	NMDA,144,148,Chemical/Drug	LY274614,168,176,Chemical/Drug	NMDA,183,187,Chemical/Drug	"[{""token"": ""amphetamine"", ""start_span"": 63, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 144, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""LY274614"", ""start_span"": 168, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Chemical/Drug""}]"	train
When CPA, diazepam or 2PAM was given immediately after DFP - atropine, these treatments prevented, delayed or shortened the occurrence of serious signs of poisoning.	CPA,5,8,Chemical/Drug	diazepam,10,18,Chemical/Drug	2PAM,22,26,Chemical/Drug	DFP,55,58,Chemical/Drug	atropine,61,69,Chemical/Drug	"[{""token"": ""CPA"", ""start_span"": 5, ""end_span"": 8, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 10, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""2PAM"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Chemical/Drug""}]"	train
In conclusion, CPA, diazepam and 2PAM in combination with atropine prevented the occurrence of serious signs of poisoning and thus reduced the toxicity of DFP in rat.	CPA,15,18,Chemical/Drug	diazepam,20,28,Chemical/Drug	2PAM,33,37,Chemical/Drug	atropine,58,66,Chemical/Drug	DFP,155,158,Chemical/Drug	"[{""token"": ""CPA"", ""start_span"": 15, ""end_span"": 18, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 20, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""2PAM"", ""start_span"": 33, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""atropine"", ""start_span"": 58, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""DFP"", ""start_span"": 155, ""end_span"": 158, ""type"": ""Chemical/Drug""}]"	train
STUDY DESIGN: We combined paclitaxel, melphalan and high - dose cyclophosphamide, thiotepa, and carboplatin in a triple sequential high - dose regimen for patients with metastatic breast cancer.	paclitaxel,26,36,Chemical/Drug	melphalan,38,47,Chemical/Drug	cyclophosphamide,64,80,Chemical/Drug	thiotepa,82,90,Chemical/Drug	carboplatin,96,107,Chemical/Drug	"[{""token"": ""paclitaxel"", ""start_span"": 26, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""melphalan"", ""start_span"": 38, ""end_span"": 47, ""type"": ""Chemical/Drug""}, {""token"": ""cyclophosphamide"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""thiotepa"", ""start_span"": 82, ""end_span"": 90, ""type"": ""Chemical/Drug""}, {""token"": ""carboplatin"", ""start_span"": 96, ""end_span"": 107, ""type"": ""Chemical/Drug""}]"	train
The finding that cocaine - and BE - induced seizures differ in several respects suggests more than one mechanism for cocaine - induced seizures and emphasizes the importance of a cocaine metabolite, BE.	cocaine,17,24,Chemical/Drug	BE,31,33,Chemical/Drug	cocaine,117,124,Chemical/Drug	cocaine,179,186,Chemical/Drug	BE,199,201,Chemical/Drug	"[{""token"": ""cocaine"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""BE"", ""start_span"": 31, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 117, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Chemical/Drug""}, {""token"": ""BE"", ""start_span"": 199, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
Fewer subjects reported adverse events following treatment with desipramine alone than when receiving desipramine with cinacalcet ( 33 versus 86%), the most frequent of which ( nausea and headache) have been reported for patients treated with either desipramine or cinacalcet.	desipramine,64,75,Chemical/Drug	desipramine,102,113,Chemical/Drug	cinacalcet,119,129,Chemical/Drug	desipramine,250,261,Chemical/Drug	cinacalcet,265,275,Chemical/Drug	"[{""token"": ""desipramine"", ""start_span"": 64, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""cinacalcet"", ""start_span"": 119, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 250, ""end_span"": 261, ""type"": ""Chemical/Drug""}, {""token"": ""cinacalcet"", ""start_span"": 265, ""end_span"": 275, ""type"": ""Chemical/Drug""}]"	train
The ACTIVE - W ( Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events) study has demonstrated that warfarin is superior to platelet therapy ( clopidogrel plus aspirin) in the prevention af embolic events.	Clopidogrel,37,48,Chemical/Drug	Irbesartan,60,70,Chemical/Drug	warfarin,134,142,Chemical/Drug	clopidogrel,177,188,Chemical/Drug	aspirin,194,201,Chemical/Drug	"[{""token"": ""Clopidogrel"", ""start_span"": 37, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""Irbesartan"", ""start_span"": 60, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""warfarin"", ""start_span"": 134, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""clopidogrel"", ""start_span"": 177, ""end_span"": 188, ""type"": ""Chemical/Drug""}, {""token"": ""aspirin"", ""start_span"": 194, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
The muscarinic receptor antagonists atropine, 4 - diphenylacetoxy - N - methylpiperidine ( 4 - DAMP) ( ' M ( 1) / M ( 3) / M ( 5) - selective '), methoctramine ( ' M ( 2) - selective ') and pirenzepine ( ' M ( 1) - selective ') antagonized the tonic component of the electrical field stimulation - evoked contractile response more potently than the phasic component.	atropine,36,44,Chemical/Drug	4 - diphenylacetoxy - N - methylpiperidine,46,88,Chemical/Drug	4 - DAMP,91,99,Chemical/Drug	methoctramine,146,159,Chemical/Drug	pirenzepine,190,201,Chemical/Drug	"[{""token"": ""atropine"", ""start_span"": 36, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""4 - diphenylacetoxy - N - methylpiperidine"", ""start_span"": 46, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""4 - DAMP"", ""start_span"": 91, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""methoctramine"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""pirenzepine"", ""start_span"": 190, ""end_span"": 201, ""type"": ""Chemical/Drug""}]"	train
Thirty male Sprague - Dawley rats were divided randomly into four treatment groups: saline, dexamethasone ( dex), allopurinol plus saline, and allopurinol plus dex.	dexamethasone,92,105,Chemical/Drug	dex,108,111,Chemical/Drug	allopurinol,114,125,Chemical/Drug	allopurinol,143,154,Chemical/Drug	dex,160,163,Chemical/Drug	"[{""token"": ""dexamethasone"", ""start_span"": 92, ""end_span"": 105, ""type"": ""Chemical/Drug""}, {""token"": ""dex"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""allopurinol"", ""start_span"": 114, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""allopurinol"", ""start_span"": 143, ""end_span"": 154, ""type"": ""Chemical/Drug""}, {""token"": ""dex"", ""start_span"": 160, ""end_span"": 163, ""type"": ""Chemical/Drug""}]"	train
Moreover, systemic lipopolysaccharide pretreatment ( 1 mg / kg) attenuated local methamphetamine infusion - produced dopamine and 3, 4 - dihydroxyphenylacetic acid depletions in the striatum, indicating that the protective effect of lipopolysaccharide is less likely due to interrupted peripheral distribution or metabolism of methamphetamine.	lipopolysaccharide,19,37,Chemical/Drug	methamphetamine,81,96,Chemical/Drug	dopamine,117,125,Chemical/Drug	lipopolysaccharide,233,251,Chemical/Drug	methamphetamine,327,342,Chemical/Drug	"[{""token"": ""lipopolysaccharide"", ""start_span"": 19, ""end_span"": 37, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 81, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 117, ""end_span"": 125, ""type"": ""Chemical/Drug""}, {""token"": ""lipopolysaccharide"", ""start_span"": 233, ""end_span"": 251, ""type"": ""Chemical/Drug""}, {""token"": ""methamphetamine"", ""start_span"": 327, ""end_span"": 342, ""type"": ""Chemical/Drug""}]"	train
Laboratory evaluation revealed 66, 680 U / L creatine kinase, 93 mg / dL blood urea nitrogen, 4. 6 mg / dL creatinine, 1579 U / L aspartate aminotransferase, and 738 U / L alanine aminotransferase.	creatine,45,53,Chemical/Drug	blood urea nitrogen,73,92,Chemical/Drug	creatinine,107,117,Chemical/Drug	aspartate,130,139,Chemical/Drug	alanine,172,179,Chemical/Drug	"[{""token"": ""creatine"", ""start_span"": 45, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""blood urea nitrogen"", ""start_span"": 73, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 107, ""end_span"": 117, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Chemical/Drug""}, {""token"": ""alanine"", ""start_span"": 172, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	train
In vivo microdialysis demonstrated that an intraperitoneal administration of pilocarpine induced a pronounced increment of hippocampal glutamate and aspartate whereas no significant change was observed on the level of glycine and GABA.	pilocarpine,77,88,Chemical/Drug	glutamate,135,144,Chemical/Drug	aspartate,149,158,Chemical/Drug	glycine,218,225,Chemical/Drug	GABA,230,234,Chemical/Drug	"[{""token"": ""pilocarpine"", ""start_span"": 77, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 135, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 149, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 218, ""end_span"": 225, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 230, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
Pretreatment with either VPU ( 50 and 100 mg / kg) or VPA ( 300 and 600 mg / kg) completely abolished pilocarpine - evoked increases in extracellular glutamate and aspartate.	VPU,25,28,Chemical/Drug	VPA,54,57,Chemical/Drug	pilocarpine,102,113,Chemical/Drug	glutamate,150,159,Chemical/Drug	aspartate,164,173,Chemical/Drug	"[{""token"": ""VPU"", ""start_span"": 25, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""VPA"", ""start_span"": 54, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""pilocarpine"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 150, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 164, ""end_span"": 173, ""type"": ""Chemical/Drug""}]"	train
Adult male albino rats, treated with ISO ( 200 mg / kg, s. c.) for 2 days at an interval of 24 h caused a significant ( P < 0. 05) elevation of heart weight, serum marker enzymes, lipid peroxidation and Ca + 2 ATPase level whereas there was a significant ( P < 0. 05) decrease in body weight, endogenous antioxidants, Na + / K + ATPase and Mg + 2 ATPase levels.	ISO,37,40,Chemical/Drug	Ca,203,205,Chemical/Drug	Na,318,320,Chemical/Drug	K,325,326,Chemical/Drug	Mg,340,342,Chemical/Drug	"[{""token"": ""ISO"", ""start_span"": 37, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 203, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 318, ""end_span"": 320, ""type"": ""Chemical/Drug""}, {""token"": ""K"", ""start_span"": 325, ""end_span"": 326, ""type"": ""Chemical/Drug""}, {""token"": ""Mg"", ""start_span"": 340, ""end_span"": 342, ""type"": ""Chemical/Drug""}]"	train
Analysis of neurotransmitter concentration in some brain regions on the test day showed that dopamine concentration of the vehicle / scopolamine group was significantly lower than that of the vehicle / vehicle group, but this phenomenon was reversed when s - limonene or s - perillyl alcohol were administered before the injection of scopolamine.	dopamine,93,101,Chemical/Drug	scopolamine,133,144,Chemical/Drug	s - limonene,255,267,Chemical/Drug	s - perillyl alcohol,271,291,Chemical/Drug	scopolamine,334,345,Chemical/Drug	"[{""token"": ""dopamine"", ""start_span"": 93, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 133, ""end_span"": 144, ""type"": ""Chemical/Drug""}, {""token"": ""s - limonene"", ""start_span"": 255, ""end_span"": 267, ""type"": ""Chemical/Drug""}, {""token"": ""s - perillyl alcohol"", ""start_span"": 271, ""end_span"": 291, ""type"": ""Chemical/Drug""}, {""token"": ""scopolamine"", ""start_span"": 334, ""end_span"": 345, ""type"": ""Chemical/Drug""}]"	train
Among them are glycine transporter - 1 ( GlyT1) inhibitors such as SSR103800, which indirectly enhance NMDA receptor function by increasing the glycine ( a co - agonist for the NMDA receptor) levels in the synapse.	glycine,15,22,Chemical/Drug	SSR103800,67,76,Chemical/Drug	NMDA,103,107,Chemical/Drug	glycine,144,151,Chemical/Drug	NMDA,177,181,Chemical/Drug	"[{""token"": ""glycine"", ""start_span"": 15, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""SSR103800"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 103, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 144, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""NMDA"", ""start_span"": 177, ""end_span"": 181, ""type"": ""Chemical/Drug""}]"	train
Adriamycinol, doxorubicin, adriamycinone, and tetrahydropyranyladriamycinol were the metabolites detected in plasma and the amount of doxorubicin was less than or equal to 10% of the total metabolites.	Adriamycinol,0,12,Chemical/Drug	doxorubicin,14,25,Chemical/Drug	adriamycinone,27,40,Chemical/Drug	tetrahydropyranyladriamycinol,46,75,Chemical/Drug	doxorubicin,134,145,Chemical/Drug	"[{""token"": ""Adriamycinol"", ""start_span"": 0, ""end_span"": 12, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 14, ""end_span"": 25, ""type"": ""Chemical/Drug""}, {""token"": ""adriamycinone"", ""start_span"": 27, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""tetrahydropyranyladriamycinol"", ""start_span"": 46, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 134, ""end_span"": 145, ""type"": ""Chemical/Drug""}]"	train
Amnesia produced by scopolamine and cycloheximide were reversed by morphine given 30 min before the test trial ( pre - test), and pre - test morphine also facilitated the memory retrieval in the animals administered naloxone during the training trial.	scopolamine,20,31,Chemical/Drug	cycloheximide,36,49,Chemical/Drug	morphine,67,75,Chemical/Drug	morphine,141,149,Chemical/Drug	naloxone,216,224,Chemical/Drug	"[{""token"": ""scopolamine"", ""start_span"": 20, ""end_span"": 31, ""type"": ""Chemical/Drug""}, {""token"": ""cycloheximide"", ""start_span"": 36, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 67, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""naloxone"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Chemical/Drug""}]"	train
During the infusion of aminophylline, the ventricular fibrillation threshold was reduced by 30 to 40 percent of the control when pH and partial pressures of oxygen ( PO2) and carbon dioxide ( CO2) were kept within normal limits.	aminophylline,23,36,Chemical/Drug	oxygen,157,163,Chemical/Drug	PO2,166,169,Chemical/Drug	carbon dioxide,175,189,Chemical/Drug	CO2,192,195,Chemical/Drug	"[{""token"": ""aminophylline"", ""start_span"": 23, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""oxygen"", ""start_span"": 157, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""PO2"", ""start_span"": 166, ""end_span"": 169, ""type"": ""Chemical/Drug""}, {""token"": ""carbon dioxide"", ""start_span"": 175, ""end_span"": 189, ""type"": ""Chemical/Drug""}, {""token"": ""CO2"", ""start_span"": 192, ""end_span"": 195, ""type"": ""Chemical/Drug""}]"	train
Pentoxifylline ( Trental) does not inhibit dipyridamole - induced coronary hyperemia: implications for dipyridamole - thallium - 201 myocardial imaging.	Pentoxifylline,0,14,Chemical/Drug	Trental,17,24,Chemical/Drug	dipyridamole,43,55,Chemical/Drug	dipyridamole,103,115,Chemical/Drug	thallium,118,126,Chemical/Drug	"[{""token"": ""Pentoxifylline"", ""start_span"": 0, ""end_span"": 14, ""type"": ""Chemical/Drug""}, {""token"": ""Trental"", ""start_span"": 17, ""end_span"": 24, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 43, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""thallium"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Chemical/Drug""}]"	train
These data indicate that ( 1) the apparent incidence of stroke related to cocaine use is increasing; ( 2) cocaine - associated stroke occurs primarily in young adults; ( 3) stroke may follow any route of cocaine administration; ( 4) stroke after cocaine use is frequently associated with intracranial aneurysms and arteriovenous malformations; and ( 5) in cocaine - associated stroke, the frequency of intracranial hemorrhage exceeds that of cerebral infarction.	cocaine,74,81,Chemical/Drug	cocaine,106,113,Chemical/Drug	cocaine,204,211,Chemical/Drug	cocaine,246,253,Chemical/Drug	cocaine,356,363,Chemical/Drug	"[{""token"": ""cocaine"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 106, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 204, ""end_span"": 211, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 246, ""end_span"": 253, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 356, ""end_span"": 363, ""type"": ""Chemical/Drug""}]"	train
Application of a delayed feedback signal, in the form of a 2 - h systemic corticosterone infusion in urethane - anesthetized rats with pharmacological blockade of glucocorticoid synthesis, is without effect on the resting secretion of arginine vasopressin and oxytocin at any corticosterone feedback dose tested.	corticosterone,74,88,Chemical/Drug	urethane,101,109,Chemical/Drug	arginine vasopressin,235,255,Chemical/Drug	oxytocin,260,268,Chemical/Drug	corticosterone,276,290,Chemical/Drug	"[{""token"": ""corticosterone"", ""start_span"": 74, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""urethane"", ""start_span"": 101, ""end_span"": 109, ""type"": ""Chemical/Drug""}, {""token"": ""arginine vasopressin"", ""start_span"": 235, ""end_span"": 255, ""type"": ""Chemical/Drug""}, {""token"": ""oxytocin"", ""start_span"": 260, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""corticosterone"", ""start_span"": 276, ""end_span"": 290, ""type"": ""Chemical/Drug""}]"	train
The multiple drug schema consisted of: Etoposide 16. 213, Methotrexate, Cyclophosphamide, Actomycin - D, and Cisplatin.	Etoposide,39,48,Chemical/Drug	Methotrexate,58,70,Chemical/Drug	Cyclophosphamide,72,88,Chemical/Drug	Actomycin - D,90,103,Chemical/Drug	Cisplatin,109,118,Chemical/Drug	"[{""token"": ""Etoposide"", ""start_span"": 39, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""Methotrexate"", ""start_span"": 58, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""Cyclophosphamide"", ""start_span"": 72, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""Actomycin - D"", ""start_span"": 90, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""Cisplatin"", ""start_span"": 109, ""end_span"": 118, ""type"": ""Chemical/Drug""}]"	train
The effects of varying the extracellular concentrations of Na and Ca ( [ Na] o and [ Ca] o) on both, the spontaneous beating and the negative chronotropic action of verapamil, were studied in the isolated rat atria.	Na,59,61,Chemical/Drug	Ca,66,68,Chemical/Drug	Na,73,75,Chemical/Drug	Ca,85,87,Chemical/Drug	verapamil,165,174,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 59, ""end_span"": 61, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 66, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 73, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 85, ""end_span"": 87, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 165, ""end_span"": 174, ""type"": ""Chemical/Drug""}]"	train
It decreased by 16 + / - 3% by lowering [ Na] o to 78 mM ( LNa), 23 + / - 2% by lowering simultaneously [ Na] o to 78 mM and [ Ca] o to 0. 675 mM ( LNa + LCa) and 31 + / - 5% by lowering [ Na] o to 78 mM plus increasing [ Ca] o to 3. 6 mM ( LNa + HCa).	Na,42,44,Chemical/Drug	Na,60,62,Chemical/Drug	Ca,127,129,Chemical/Drug	Na,149,151,Chemical/Drug	Ca,155,157,Chemical/Drug	"[{""token"": ""Na"", ""start_span"": 42, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 60, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 127, ""end_span"": 129, ""type"": ""Chemical/Drug""}, {""token"": ""Na"", ""start_span"": 149, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""Ca"", ""start_span"": 155, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
The pathogenesis of 5 - fluorouracil neurotoxicity may be due to a Krebs cycle blockade by fluoroacetate and fluorocitrate, thiamine deficiency, or dihydrouracil dehydrogenase deficiency.	5 - fluorouracil,20,36,Chemical/Drug	fluoroacetate,91,104,Chemical/Drug	fluorocitrate,109,122,Chemical/Drug	thiamine,124,132,Chemical/Drug	dihydrouracil,148,161,Chemical/Drug	"[{""token"": ""5 - fluorouracil"", ""start_span"": 20, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""fluoroacetate"", ""start_span"": 91, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""fluorocitrate"", ""start_span"": 109, ""end_span"": 122, ""type"": ""Chemical/Drug""}, {""token"": ""thiamine"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""dihydrouracil"", ""start_span"": 148, ""end_span"": 161, ""type"": ""Chemical/Drug""}]"	train
Carbamazepine was switched to its 10 - keto analogue oxcarbazepine among six difficult - to - treat schizophrenic or organic psychotic patients using concomitantly haloperidol, chlorpromazine or clozapine.	Carbamazepine,0,13,Chemical/Drug	oxcarbazepine,53,66,Chemical/Drug	haloperidol,164,175,Chemical/Drug	chlorpromazine,177,191,Chemical/Drug	clozapine,195,204,Chemical/Drug	"[{""token"": ""Carbamazepine"", ""start_span"": 0, ""end_span"": 13, ""type"": ""Chemical/Drug""}, {""token"": ""oxcarbazepine"", ""start_span"": 53, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""haloperidol"", ""start_span"": 164, ""end_span"": 175, ""type"": ""Chemical/Drug""}, {""token"": ""chlorpromazine"", ""start_span"": 177, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""clozapine"", ""start_span"": 195, ""end_span"": 204, ""type"": ""Chemical/Drug""}]"	train
For each of the three tested calcium channel blockers ( diltiazem, verapamil and bepridil) 6 groups of mice were treated by two different doses, i. e. 2 and 10 mg / kg / i. p., or an equal volume of saline for the control group ( n = 20); 15 minutes later, all the animals were injected with a single 50 mg / kg / i. p. dose of bupivacaine.	calcium,29,36,Chemical/Drug	diltiazem,56,65,Chemical/Drug	verapamil,67,76,Chemical/Drug	bepridil,81,89,Chemical/Drug	bupivacaine,328,339,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 29, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""diltiazem"", ""start_span"": 56, ""end_span"": 65, ""type"": ""Chemical/Drug""}, {""token"": ""verapamil"", ""start_span"": 67, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""bepridil"", ""start_span"": 81, ""end_span"": 89, ""type"": ""Chemical/Drug""}, {""token"": ""bupivacaine"", ""start_span"": 328, ""end_span"": 339, ""type"": ""Chemical/Drug""}]"	train
To evaluate the effect of prostaglandin E1 ( PGE1) or trimethaphan ( TMP) induced hypotension on epidural blood flow ( EBF) during spinal surgery, EBF was measured using the heat clearance method in 30 patients who underwent postero - lateral interbody fusion under isoflurane anaesthesia.	prostaglandin E1,26,42,Chemical/Drug	PGE1,45,49,Chemical/Drug	trimethaphan,54,66,Chemical/Drug	TMP,69,72,Chemical/Drug	isoflurane,266,276,Chemical/Drug	"[{""token"": ""prostaglandin E1"", ""start_span"": 26, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""PGE1"", ""start_span"": 45, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""trimethaphan"", ""start_span"": 54, ""end_span"": 66, ""type"": ""Chemical/Drug""}, {""token"": ""TMP"", ""start_span"": 69, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""isoflurane"", ""start_span"": 266, ""end_span"": 276, ""type"": ""Chemical/Drug""}]"	train
The appearance of nephrotic syndromes such as proteinuria, hypoalbuminemia, hypercholesterolemia and increase in blood nitrogen urea, induced in rats by injection of puromycin aminonucleoside was markedly inhibited by oral administration of Dup 753 ( losartan), a novel angiotensin II receptor antagonist, at a dose of 1 or 2 mg / kg per day.	blood nitrogen urea,113,132,Chemical/Drug	puromycin aminonucleoside,166,191,Chemical/Drug	Dup 753,241,248,Chemical/Drug	losartan,251,259,Chemical/Drug	angiotensin II,270,284,Chemical/Drug	"[{""token"": ""blood nitrogen urea"", ""start_span"": 113, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""puromycin aminonucleoside"", ""start_span"": 166, ""end_span"": 191, ""type"": ""Chemical/Drug""}, {""token"": ""Dup 753"", ""start_span"": 241, ""end_span"": 248, ""type"": ""Chemical/Drug""}, {""token"": ""losartan"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Chemical/Drug""}, {""token"": ""angiotensin II"", ""start_span"": 270, ""end_span"": 284, ""type"": ""Chemical/Drug""}]"	train
After the administration of NG, 5 - FU and CY neither a statistically significant increase in creatinine concentration nor an increase in creatinine clearance was observed compared to the group receiving no cytostatics.	NG,28,30,Chemical/Drug	5 - FU,32,38,Chemical/Drug	CY,43,45,Chemical/Drug	creatinine,94,104,Chemical/Drug	creatinine,138,148,Chemical/Drug	"[{""token"": ""NG"", ""start_span"": 28, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 32, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""CY"", ""start_span"": 43, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 94, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 138, ""end_span"": 148, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: Hydrochlorofluorocarbons ( HCFCs) are used increasingly in industry as substitutes for ozone - depleting chlorofluorocarbons ( CFCs).	Hydrochlorofluorocarbons,12,36,Chemical/Drug	HCFCs,39,44,Chemical/Drug	ozone,99,104,Chemical/Drug	chlorofluorocarbons,117,136,Chemical/Drug	CFCs,139,143,Chemical/Drug	"[{""token"": ""Hydrochlorofluorocarbons"", ""start_span"": 12, ""end_span"": 36, ""type"": ""Chemical/Drug""}, {""token"": ""HCFCs"", ""start_span"": 39, ""end_span"": 44, ""type"": ""Chemical/Drug""}, {""token"": ""ozone"", ""start_span"": 99, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""chlorofluorocarbons"", ""start_span"": 117, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""CFCs"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Chemical/Drug""}]"	train
Combination chemotherapy with mitoxantrone, high - dose 5 - fluorouracil ( 5 - FU) and leucovorin ( MFL regimen) had been reported as an effective and well tolerated regimen.	mitoxantrone,30,42,Chemical/Drug	5 - fluorouracil,56,72,Chemical/Drug	5 - FU,75,81,Chemical/Drug	leucovorin,87,97,Chemical/Drug	MFL regimen,100,111,Chemical/Drug	"[{""token"": ""mitoxantrone"", ""start_span"": 30, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""5 - fluorouracil"", ""start_span"": 56, ""end_span"": 72, ""type"": ""Chemical/Drug""}, {""token"": ""5 - FU"", ""start_span"": 75, ""end_span"": 81, ""type"": ""Chemical/Drug""}, {""token"": ""leucovorin"", ""start_span"": 87, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""MFL regimen"", ""start_span"": 100, ""end_span"": 111, ""type"": ""Chemical/Drug""}]"	train
Mitochondrial radiocalcium uptakes were significantly decreased in animals pretreated with acetylsalicylic acid or dipyridamole or when hydrocortisone was added to the epinephrine infusion ( 2, 682, 2, 803, and 3, 424 counts per minute per gram of dried fraction, respectively).	radiocalcium,14,26,Chemical/Drug	acetylsalicylic acid,91,111,Chemical/Drug	dipyridamole,115,127,Chemical/Drug	hydrocortisone,136,150,Chemical/Drug	epinephrine,168,179,Chemical/Drug	"[{""token"": ""radiocalcium"", ""start_span"": 14, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""acetylsalicylic acid"", ""start_span"": 91, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""dipyridamole"", ""start_span"": 115, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""hydrocortisone"", ""start_span"": 136, ""end_span"": 150, ""type"": ""Chemical/Drug""}, {""token"": ""epinephrine"", ""start_span"": 168, ""end_span"": 179, ""type"": ""Chemical/Drug""}]"	train
We recently showed elevated reactive oxygen species ( ROS), reduced urinary excretion of NO metabolites ( NOx), and increased NO sequestration as nitrotyrosine in various tissues in rats with lead - induced hypertension.	oxygen,37,43,Chemical/Drug	NO,89,91,Chemical/Drug	NO,106,108,Chemical/Drug	nitrotyrosine,146,159,Chemical/Drug	lead,192,196,Chemical/Drug	"[{""token"": ""oxygen"", ""start_span"": 37, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""NO"", ""start_span"": 106, ""end_span"": 108, ""type"": ""Chemical/Drug""}, {""token"": ""nitrotyrosine"", ""start_span"": 146, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""lead"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Chemical/Drug""}]"	train
Male Sprague - Dawley rats were randomly assigned to a lead - treated group ( given lead acetate, 100 ppm, in drinking water and regular rat chow), a group given lead and vitamin E - fortified chow, or a normal control group given either regular food and water or vitamin E - fortified food for 12 weeks.	lead,55,59,Chemical/Drug	lead acetate,84,96,Chemical/Drug	lead,162,166,Chemical/Drug	vitamin E,171,180,Chemical/Drug	vitamin E,264,273,Chemical/Drug	"[{""token"": ""lead"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""lead acetate"", ""start_span"": 84, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""lead"", ""start_span"": 162, ""end_span"": 166, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 171, ""end_span"": 180, ""type"": ""Chemical/Drug""}, {""token"": ""vitamin E"", ""start_span"": 264, ""end_span"": 273, ""type"": ""Chemical/Drug""}]"	train
BACKGROUND: The aim of this study is to evaluate the effects of RAPA conversion in patients undergoing cyclosporine ( CsA) or tacrolimus ( Tac) toxicity.	RAPA,64,68,Chemical/Drug	cyclosporine,103,115,Chemical/Drug	CsA,118,121,Chemical/Drug	tacrolimus,126,136,Chemical/Drug	Tac,139,142,Chemical/Drug	"[{""token"": ""RAPA"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""cyclosporine"", ""start_span"": 103, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""CsA"", ""start_span"": 118, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""tacrolimus"", ""start_span"": 126, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""Tac"", ""start_span"": 139, ""end_span"": 142, ""type"": ""Chemical/Drug""}]"	train
The patients concurrent medications included didanosine, hydroxyzine, promethazine, hydrocortisone, and prochlorperazine.	didanosine,45,55,Chemical/Drug	hydroxyzine,57,68,Chemical/Drug	promethazine,70,82,Chemical/Drug	hydrocortisone,84,98,Chemical/Drug	prochlorperazine,104,120,Chemical/Drug	"[{""token"": ""didanosine"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""hydroxyzine"", ""start_span"": 57, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""promethazine"", ""start_span"": 70, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""hydrocortisone"", ""start_span"": 84, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""prochlorperazine"", ""start_span"": 104, ""end_span"": 120, ""type"": ""Chemical/Drug""}]"	train
Intracerebroventricular injection of atropine, hexamethonium, and naloxone also decreased catalepsy induced by morphine plus nicotine.	atropine,37,45,Chemical/Drug	hexamethonium,47,60,Chemical/Drug	naloxone,66,74,Chemical/Drug	morphine,111,119,Chemical/Drug	nicotine,125,133,Chemical/Drug	"[{""token"": ""atropine"", ""start_span"": 37, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""hexamethonium"", ""start_span"": 47, ""end_span"": 60, ""type"": ""Chemical/Drug""}, {""token"": ""naloxone"", ""start_span"": 66, ""end_span"": 74, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 111, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Chemical/Drug""}]"	train
From day 0 to day 3, the mean peak increase in creatinine was 0. 13 mg per deciliter in the iodixanol group and 0. 55 mg per deciliter in the iohexol group ( P = 0. 001; the increase with iodixanol minus the increase with iohexol, - 0. 42 mg per deciliter [ 95 percent confidence interval, - 0. 73 to - 0. 22]).	creatinine,47,57,Chemical/Drug	iodixanol,92,101,Chemical/Drug	iohexol,142,149,Chemical/Drug	iodixanol,188,197,Chemical/Drug	iohexol,222,229,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 92, ""end_span"": 101, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 142, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 188, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 222, ""end_span"": 229, ""type"": ""Chemical/Drug""}]"	train
The mean change in the creatinine concentration from day 0 to day 7 was 0. 07 mg per deciliter in the iodixanol group and 0. 24 mg per deciliter in the iohexol group ( P = 0. 003; value in the iodixanol group minus the value in the iohexol group, - 0. 17 mg per deciliter [ 95 percent confidence interval, - 0. 34 to - 0. 07]).	creatinine,23,33,Chemical/Drug	iodixanol,102,111,Chemical/Drug	iohexol,152,159,Chemical/Drug	iodixanol,193,202,Chemical/Drug	iohexol,232,239,Chemical/Drug	"[{""token"": ""creatinine"", ""start_span"": 23, ""end_span"": 33, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""iodixanol"", ""start_span"": 193, ""end_span"": 202, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 232, ""end_span"": 239, ""type"": ""Chemical/Drug""}]"	train
Similarly, when the P450 - mediated metabolism of lindane was blocked by cobalt chloride incidence of convulsions was increased in animals treated with lindane indicating that lindane per se or its metabolites formed by PB or ethanol inducible P450 isoenzymes are involved in its neurobehavioral toxicity.	lindane,50,57,Chemical/Drug	cobalt chloride,73,88,Chemical/Drug	lindane,152,159,Chemical/Drug	lindane,176,183,Chemical/Drug	ethanol,226,233,Chemical/Drug	"[{""token"": ""lindane"", ""start_span"": 50, ""end_span"": 57, ""type"": ""Chemical/Drug""}, {""token"": ""cobalt chloride"", ""start_span"": 73, ""end_span"": 88, ""type"": ""Chemical/Drug""}, {""token"": ""lindane"", ""start_span"": 152, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""lindane"", ""start_span"": 176, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 226, ""end_span"": 233, ""type"": ""Chemical/Drug""}]"	train
The corresponding absolute risk of VTE was 3. 4 ( range, 3. 1 - 3. 8) per 10 000 women years among the women on COCs, 4. 2 ( range, 3. 2 - 5. 2) per 10 000 women years among women on levonorgestrel - containing COCs, and 3. 1 ( range, 1. 3 - 4. 9) per 10 000 women years among the women on CPA / EE.	COCs,112,116,Chemical/Drug	levonorgestrel,183,197,Chemical/Drug	COCs,211,215,Chemical/Drug	CPA,290,293,Chemical/Drug	EE,296,298,Chemical/Drug	"[{""token"": ""COCs"", ""start_span"": 112, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""levonorgestrel"", ""start_span"": 183, ""end_span"": 197, ""type"": ""Chemical/Drug""}, {""token"": ""COCs"", ""start_span"": 211, ""end_span"": 215, ""type"": ""Chemical/Drug""}, {""token"": ""CPA"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Chemical/Drug""}, {""token"": ""EE"", ""start_span"": 296, ""end_span"": 298, ""type"": ""Chemical/Drug""}]"	train
Flumazenil ( mean dose, 0. 76 mg) or placebo ( mean dose, 8. 9 ml) was administered intravenously to 130 and 67 patients, respectively, who had been given diazepam in conjunction with an opioid ( fentanyl, meperidine, or morphine) for the induction and maintenance of intravenous conscious sedation for diagnostic or therapeutic surgical procedures.	Flumazenil,0,10,Chemical/Drug	diazepam,155,163,Chemical/Drug	fentanyl,196,204,Chemical/Drug	meperidine,206,216,Chemical/Drug	morphine,221,229,Chemical/Drug	"[{""token"": ""Flumazenil"", ""start_span"": 0, ""end_span"": 10, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 155, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""fentanyl"", ""start_span"": 196, ""end_span"": 204, ""type"": ""Chemical/Drug""}, {""token"": ""meperidine"", ""start_span"": 206, ""end_span"": 216, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 221, ""end_span"": 229, ""type"": ""Chemical/Drug""}]"	train
On the other hand, bicuculline, aminophylline and BAY k - 8644 inhibited the anticonvulsive action of loreclezole combined with clonazepam.	bicuculline,19,30,Chemical/Drug	aminophylline,32,45,Chemical/Drug	BAY k - 8644,50,62,Chemical/Drug	loreclezole,102,113,Chemical/Drug	clonazepam,128,138,Chemical/Drug	"[{""token"": ""bicuculline"", ""start_span"": 19, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""aminophylline"", ""start_span"": 32, ""end_span"": 45, ""type"": ""Chemical/Drug""}, {""token"": ""BAY k - 8644"", ""start_span"": 50, ""end_span"": 62, ""type"": ""Chemical/Drug""}, {""token"": ""loreclezole"", ""start_span"": 102, ""end_span"": 113, ""type"": ""Chemical/Drug""}, {""token"": ""clonazepam"", ""start_span"": 128, ""end_span"": 138, ""type"": ""Chemical/Drug""}]"	train
PURPOSE: The anthracyclines daunorubicin and doxorubicin and the epipodophyllotoxin etoposide are potent DNA cleavage - enhancing drugs that are widely used in clinical oncology; however, myelosuppression and cardiac toxicity limit their use.	anthracyclines,13,27,Chemical/Drug	daunorubicin,28,40,Chemical/Drug	doxorubicin,45,56,Chemical/Drug	epipodophyllotoxin,65,83,Chemical/Drug	etoposide,84,93,Chemical/Drug	"[{""token"": ""anthracyclines"", ""start_span"": 13, ""end_span"": 27, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 45, ""end_span"": 56, ""type"": ""Chemical/Drug""}, {""token"": ""epipodophyllotoxin"", ""start_span"": 65, ""end_span"": 83, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 84, ""end_span"": 93, ""type"": ""Chemical/Drug""}]"	train
EXPERIMENTAL DESIGN: Because of their widespread use, the hematologic toxicity following coadministration of dexrazoxane and these three structurally different DNA cleavage enhancers was investigated: Sensitivity of human and murine blood progenitor cells to etoposide, daunorubicin, and doxorubicin + / - dexrazoxane was determined in granulocyte - macrophage colony forming assays.	dexrazoxane,109,120,Chemical/Drug	etoposide,259,268,Chemical/Drug	daunorubicin,270,282,Chemical/Drug	doxorubicin,288,299,Chemical/Drug	dexrazoxane,306,317,Chemical/Drug	"[{""token"": ""dexrazoxane"", ""start_span"": 109, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 259, ""end_span"": 268, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 270, ""end_span"": 282, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 288, ""end_span"": 299, ""type"": ""Chemical/Drug""}, {""token"": ""dexrazoxane"", ""start_span"": 306, ""end_span"": 317, ""type"": ""Chemical/Drug""}]"	train
RESULTS: Nontoxic doses of dexrazoxane reduced myelosuppression and weight loss from daunorubicin and etoposide in mice and antagonized their antiproliferative effects in the colony assay; however, dexrazoxane neither reduced myelosuppression, weight loss, nor the in vitro cytotoxicity from doxorubicin.	dexrazoxane,27,38,Chemical/Drug	daunorubicin,85,97,Chemical/Drug	etoposide,102,111,Chemical/Drug	dexrazoxane,198,209,Chemical/Drug	doxorubicin,292,303,Chemical/Drug	"[{""token"": ""dexrazoxane"", ""start_span"": 27, ""end_span"": 38, ""type"": ""Chemical/Drug""}, {""token"": ""daunorubicin"", ""start_span"": 85, ""end_span"": 97, ""type"": ""Chemical/Drug""}, {""token"": ""etoposide"", ""start_span"": 102, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""dexrazoxane"", ""start_span"": 198, ""end_span"": 209, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 292, ""end_span"": 303, ""type"": ""Chemical/Drug""}]"	train
Subcutaneous injection of ISPH ( 200 mg / kg body weight in 1 ml saline) to rats for 2 consecutive days caused myocardial damage in rat heart, which was determined by the increased activity of serum lactate dehydrogenase ( LDH) and creatine phosphokinase isoenzymes ( CK - MB), increased uric acid level and reduced plasma iron binding capacity.	ISPH,26,30,Chemical/Drug	lactate,199,206,Chemical/Drug	creatine,232,240,Chemical/Drug	uric acid,288,297,Chemical/Drug	iron,323,327,Chemical/Drug	"[{""token"": ""ISPH"", ""start_span"": 26, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""lactate"", ""start_span"": 199, ""end_span"": 206, ""type"": ""Chemical/Drug""}, {""token"": ""creatine"", ""start_span"": 232, ""end_span"": 240, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 288, ""end_span"": 297, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 323, ""end_span"": 327, ""type"": ""Chemical/Drug""}]"	train
Co - administration of lidocaine with desipramine reversed the changes of convulsive activity of lidocaine and cocaine induced by repeated administration of desipramine.	lidocaine,23,32,Chemical/Drug	desipramine,38,49,Chemical/Drug	lidocaine,97,106,Chemical/Drug	cocaine,111,118,Chemical/Drug	desipramine,157,168,Chemical/Drug	"[{""token"": ""lidocaine"", ""start_span"": 23, ""end_span"": 32, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 38, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""lidocaine"", ""start_span"": 97, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""cocaine"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""desipramine"", ""start_span"": 157, ""end_span"": 168, ""type"": ""Chemical/Drug""}]"	train
To assess the antioxidant effects of atorvastatin ( atorva) on dexamethasone ( dex) - induced hypertension, 60 male Sprague - Dawley rats were treated with atorva 30 mg / kg / day or tap water for 15 days.	atorvastatin,37,49,Chemical/Drug	atorva,52,58,Chemical/Drug	dexamethasone,63,76,Chemical/Drug	dex,79,82,Chemical/Drug	atorva,156,162,Chemical/Drug	"[{""token"": ""atorvastatin"", ""start_span"": 37, ""end_span"": 49, ""type"": ""Chemical/Drug""}, {""token"": ""atorva"", ""start_span"": 52, ""end_span"": 58, ""type"": ""Chemical/Drug""}, {""token"": ""dexamethasone"", ""start_span"": 63, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""dex"", ""start_span"": 79, ""end_span"": 82, ""type"": ""Chemical/Drug""}, {""token"": ""atorva"", ""start_span"": 156, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
D - 1 agonist SKF 38393 or D - 2 agonist quinpirole decreased the catalepsy induced by fluphenazine, SCH 23390 or sulpiride.	SKF 38393,14,23,Chemical/Drug	quinpirole,41,51,Chemical/Drug	fluphenazine,87,99,Chemical/Drug	SCH 23390,101,110,Chemical/Drug	sulpiride,114,123,Chemical/Drug	"[{""token"": ""SKF 38393"", ""start_span"": 14, ""end_span"": 23, ""type"": ""Chemical/Drug""}, {""token"": ""quinpirole"", ""start_span"": 41, ""end_span"": 51, ""type"": ""Chemical/Drug""}, {""token"": ""fluphenazine"", ""start_span"": 87, ""end_span"": 99, ""type"": ""Chemical/Drug""}, {""token"": ""SCH 23390"", ""start_span"": 101, ""end_span"": 110, ""type"": ""Chemical/Drug""}, {""token"": ""sulpiride"", ""start_span"": 114, ""end_span"": 123, ""type"": ""Chemical/Drug""}]"	train
Similarly, EPS - related adverse events with QTP + Li / DVP ( 21. 4%) were no different than with PBO + Li / DVP ( 19. 2%).	QTP,45,48,Chemical/Drug	Li,51,53,Chemical/Drug	DVP,56,59,Chemical/Drug	Li,104,106,Chemical/Drug	DVP,109,112,Chemical/Drug	"[{""token"": ""QTP"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Chemical/Drug""}, {""token"": ""Li"", ""start_span"": 51, ""end_span"": 53, ""type"": ""Chemical/Drug""}, {""token"": ""DVP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""Li"", ""start_span"": 104, ""end_span"": 106, ""type"": ""Chemical/Drug""}, {""token"": ""DVP"", ""start_span"": 109, ""end_span"": 112, ""type"": ""Chemical/Drug""}]"	train
To demonstrate the relationship between peripheral iron overload and dopaminergic neuron loss in rat substantia nigra ( SN), in the present study we used fast cyclic voltammetry, tyrosine hydroxylase ( TH) immunohistochemistry, Perls ' iron staining, and high performance liquid chromatography - electrochemical detection to study the degeneration of dopaminergic neurons and increased iron content in the SN of iron dextran overloaded animals.	iron,51,55,Chemical/Drug	tyrosine,179,187,Chemical/Drug	iron,236,240,Chemical/Drug	iron,386,390,Chemical/Drug	iron dextran,412,424,Chemical/Drug	"[{""token"": ""iron"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Chemical/Drug""}, {""token"": ""tyrosine"", ""start_span"": 179, ""end_span"": 187, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 236, ""end_span"": 240, ""type"": ""Chemical/Drug""}, {""token"": ""iron"", ""start_span"": 386, ""end_span"": 390, ""type"": ""Chemical/Drug""}, {""token"": ""iron dextran"", ""start_span"": 412, ""end_span"": 424, ""type"": ""Chemical/Drug""}]"	train
Blood samples for the analysis of plasma potassium, terbutaline, metoprolol ( racemic, R - and S - isomer), and alpha - hydroxymetoprolol concentrations were taken at regular time intervals, during 8 hr after metoprolol.	potassium,41,50,Chemical/Drug	terbutaline,52,63,Chemical/Drug	metoprolol,65,75,Chemical/Drug	alpha - hydroxymetoprolol,112,137,Chemical/Drug	metoprolol,209,219,Chemical/Drug	"[{""token"": ""potassium"", ""start_span"": 41, ""end_span"": 50, ""type"": ""Chemical/Drug""}, {""token"": ""terbutaline"", ""start_span"": 52, ""end_span"": 63, ""type"": ""Chemical/Drug""}, {""token"": ""metoprolol"", ""start_span"": 65, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""alpha - hydroxymetoprolol"", ""start_span"": 112, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""metoprolol"", ""start_span"": 209, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	train
Mechanistic studies revealed that OB rats are sensitized due to: ( 1) higher oxyradical stress leading to upregulation of uncoupling proteins 2 and 3, ( 2) downregulation of cardiac peroxisome proliferators activated receptor - alpha, ( 3) decreased plasma adiponectin levels, ( 4) decreased cardiac fatty - acid oxidation ( 666. 9 + / - 14. 0 nmol / min / g heart in ND versus 400. 2 + / - 11. 8 nmol / min / g heart in OB), ( 5) decreased mitochondrial AMP - alpha2 protein kinase, and ( 6) 86% drop in cardiac ATP levels accompanied by decreased ATP / ADP ratio after doxorubicin administration.	AMP,455,458,Chemical/Drug	ATP,513,516,Chemical/Drug	ATP,549,552,Chemical/Drug	ADP,555,558,Chemical/Drug	doxorubicin,571,582,Chemical/Drug	"[{""token"": ""AMP"", ""start_span"": 455, ""end_span"": 458, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 513, ""end_span"": 516, ""type"": ""Chemical/Drug""}, {""token"": ""ATP"", ""start_span"": 549, ""end_span"": 552, ""type"": ""Chemical/Drug""}, {""token"": ""ADP"", ""start_span"": 555, ""end_span"": 558, ""type"": ""Chemical/Drug""}, {""token"": ""doxorubicin"", ""start_span"": 571, ""end_span"": 582, ""type"": ""Chemical/Drug""}]"	train
The beneficial effects of vitamin C administration to gentamicin - treated animals are also confirmed through: lower level of blood urea and creatinine and higher level of potassium.	vitamin C,26,35,Chemical/Drug	gentamicin,54,64,Chemical/Drug	urea,132,136,Chemical/Drug	creatinine,141,151,Chemical/Drug	potassium,172,181,Chemical/Drug	"[{""token"": ""vitamin C"", ""start_span"": 26, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""gentamicin"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 141, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""potassium"", ""start_span"": 172, ""end_span"": 181, ""type"": ""Chemical/Drug""}]"	train
Ninety - six Swiss - Webster mice ( 30 - 35 g, 6 - 8 wk), were randomized into 6 groups 1) saline ( control), 2) NTG immediately after learning, 3) NTG 3 h after learning, 4) NTG and NIMO, 5) vehicle, and 6) NIMO alone.	NTG,113,116,Chemical/Drug	NTG,148,151,Chemical/Drug	NTG,175,178,Chemical/Drug	NIMO,183,187,Chemical/Drug	NIMO,208,212,Chemical/Drug	"[{""token"": ""NTG"", ""start_span"": 113, ""end_span"": 116, ""type"": ""Chemical/Drug""}, {""token"": ""NTG"", ""start_span"": 148, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""NTG"", ""start_span"": 175, ""end_span"": 178, ""type"": ""Chemical/Drug""}, {""token"": ""NIMO"", ""start_span"": 183, ""end_span"": 187, ""type"": ""Chemical/Drug""}, {""token"": ""NIMO"", ""start_span"": 208, ""end_span"": 212, ""type"": ""Chemical/Drug""}]"	train
This prospective study determined the incidence of CIN for two nonionic contrast media ( CM), iopromide and iohexol, among 80 patients younger than 18 years and compared the rates for this complication in relation to the type and dosage of CM and the presence of cyanosis.	contrast media,72,86,Chemical/Drug	CM,89,91,Chemical/Drug	iopromide,94,103,Chemical/Drug	iohexol,108,115,Chemical/Drug	CM,240,242,Chemical/Drug	"[{""token"": ""contrast media"", ""start_span"": 72, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""CM"", ""start_span"": 89, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""iopromide"", ""start_span"": 94, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""iohexol"", ""start_span"": 108, ""end_span"": 115, ""type"": ""Chemical/Drug""}, {""token"": ""CM"", ""start_span"": 240, ""end_span"": 242, ""type"": ""Chemical/Drug""}]"	train
Compound 1 is a potent A ( 2A) / A ( 1) receptor antagonist in vitro ( A ( 2A) K ( i) = 4. 1 nM; A ( 1) K ( i) = 17. 0 nM) that has excellent activity, after oral administration, across a number of animal models of Parkinson ' s disease including mouse and rat models of haloperidol - induced catalepsy, mouse model of reserpine - induced akinesia, rat 6 - hydroxydopamine ( 6 - OHDA) lesion model of drug - induced rotation, and MPTP - treated non - human primate model.	haloperidol,271,282,Chemical/Drug	reserpine,319,328,Chemical/Drug	6 - hydroxydopamine,353,372,Chemical/Drug	6 - OHDA,375,383,Chemical/Drug	MPTP,430,434,Chemical/Drug	"[{""token"": ""haloperidol"", ""start_span"": 271, ""end_span"": 282, ""type"": ""Chemical/Drug""}, {""token"": ""reserpine"", ""start_span"": 319, ""end_span"": 328, ""type"": ""Chemical/Drug""}, {""token"": ""6 - hydroxydopamine"", ""start_span"": 353, ""end_span"": 372, ""type"": ""Chemical/Drug""}, {""token"": ""6 - OHDA"", ""start_span"": 375, ""end_span"": 383, ""type"": ""Chemical/Drug""}, {""token"": ""MPTP"", ""start_span"": 430, ""end_span"": 434, ""type"": ""Chemical/Drug""}]"	train
Pre - treatment with ketamine produced cross - tolerance to morphine, whereas pretreatment with morphine did not induce cross - tolerance to ketamine but rather augmented the cataleptic response; this augmentation was attributed to residual morphine in the brain.	ketamine,21,29,Chemical/Drug	morphine,60,68,Chemical/Drug	morphine,96,104,Chemical/Drug	ketamine,141,149,Chemical/Drug	morphine,241,249,Chemical/Drug	"[{""token"": ""ketamine"", ""start_span"": 21, ""end_span"": 29, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 60, ""end_span"": 68, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 141, ""end_span"": 149, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 241, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	train
25 mg / kg, i. v. thiopental produced anesthesia without altering respiratory rate, increased GABA, decreased glutamate, and had no effect on aspartate or glycine levels compared to controls in rat cortex and brain stem.	thiopental,18,28,Chemical/Drug	GABA,94,98,Chemical/Drug	glutamate,110,119,Chemical/Drug	aspartate,142,151,Chemical/Drug	glycine,155,162,Chemical/Drug	"[{""token"": ""thiopental"", ""start_span"": 18, ""end_span"": 28, ""type"": ""Chemical/Drug""}, {""token"": ""GABA"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Chemical/Drug""}, {""token"": ""glutamate"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""aspartate"", ""start_span"": 142, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""glycine"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Chemical/Drug""}]"	train
In rats which were pretreated with nicotine for 5 days, there was a significant increase in the nicotine - stimulated locomotor response which was associated with an increase in the number of L - [ 3H] nicotine binding sites and also with an elevated dopamine ( DA) level in the striatum.	nicotine,35,43,Chemical/Drug	nicotine,96,104,Chemical/Drug	nicotine,202,210,Chemical/Drug	dopamine,251,259,Chemical/Drug	DA,262,264,Chemical/Drug	"[{""token"": ""nicotine"", ""start_span"": 35, ""end_span"": 43, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""nicotine"", ""start_span"": 202, ""end_span"": 210, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 251, ""end_span"": 259, ""type"": ""Chemical/Drug""}, {""token"": ""DA"", ""start_span"": 262, ""end_span"": 264, ""type"": ""Chemical/Drug""}]"	train
Acute experimental models of renal damage to the proximal tubular, glomerular, and papillary regions of the rat were produced by administration of hexachloro - 1: 3 - butadiene ( HCBD), puromycin aminonucleoside ( PAN), and 2 - bromoethylamine ( BEA), respectively.	HCBD,179,183,Chemical/Drug	puromycin aminonucleoside,186,211,Chemical/Drug	PAN,214,217,Chemical/Drug	2 - bromoethylamine,224,243,Chemical/Drug	BEA,246,249,Chemical/Drug	"[{""token"": ""HCBD"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Chemical/Drug""}, {""token"": ""puromycin aminonucleoside"", ""start_span"": 186, ""end_span"": 211, ""type"": ""Chemical/Drug""}, {""token"": ""PAN"", ""start_span"": 214, ""end_span"": 217, ""type"": ""Chemical/Drug""}, {""token"": ""2 - bromoethylamine"", ""start_span"": 224, ""end_span"": 243, ""type"": ""Chemical/Drug""}, {""token"": ""BEA"", ""start_span"": 246, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	train
The combined administration of CSA and various chemotherapeutic drugs with a nephrotoxic potential, such as gentamicin ( at therapeutic doses), amphothericin B and ketoconazole, which are frequently used in immunosuppressed patients, did not aggravate the CSA induced toxicity in the rat model.	CSA,31,34,Chemical/Drug	gentamicin,108,118,Chemical/Drug	amphothericin B,144,159,Chemical/Drug	ketoconazole,164,176,Chemical/Drug	CSA,256,259,Chemical/Drug	"[{""token"": ""CSA"", ""start_span"": 31, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""gentamicin"", ""start_span"": 108, ""end_span"": 118, ""type"": ""Chemical/Drug""}, {""token"": ""amphothericin B"", ""start_span"": 144, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""ketoconazole"", ""start_span"": 164, ""end_span"": 176, ""type"": ""Chemical/Drug""}, {""token"": ""CSA"", ""start_span"": 256, ""end_span"": 259, ""type"": ""Chemical/Drug""}]"	train
Treatment with high doses of cimetidine ( one to 60 months; median, 11 months) or ranitidine ( two to 31 months; median, 14 months) was not associated with hepatic or hematologic toxicity or alterations of serum gastrin concentrations, but ranitidine therapy was associated with a significantly lower serum creatinine level than seen with cimetidine therapy.	cimetidine,29,39,Chemical/Drug	ranitidine,82,92,Chemical/Drug	ranitidine,240,250,Chemical/Drug	creatinine,307,317,Chemical/Drug	cimetidine,339,349,Chemical/Drug	"[{""token"": ""cimetidine"", ""start_span"": 29, ""end_span"": 39, ""type"": ""Chemical/Drug""}, {""token"": ""ranitidine"", ""start_span"": 82, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""ranitidine"", ""start_span"": 240, ""end_span"": 250, ""type"": ""Chemical/Drug""}, {""token"": ""creatinine"", ""start_span"": 307, ""end_span"": 317, ""type"": ""Chemical/Drug""}, {""token"": ""cimetidine"", ""start_span"": 339, ""end_span"": 349, ""type"": ""Chemical/Drug""}]"	train
Pretreatment with ammonium acetate ( NH4Ac) ( 6 mmol / kg s. c.) approximately doubled the time morphine - treated mice remained on a hot surface and similarly increased muscular incoordination by diazepam, but NH4Ac treatment alone had no effect.	ammonium acetate,18,34,Chemical/Drug	NH4Ac,37,42,Chemical/Drug	morphine,96,104,Chemical/Drug	diazepam,197,205,Chemical/Drug	NH4Ac,211,216,Chemical/Drug	"[{""token"": ""ammonium acetate"", ""start_span"": 18, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Chemical/Drug""}, {""token"": ""morphine"", ""start_span"": 96, ""end_span"": 104, ""type"": ""Chemical/Drug""}, {""token"": ""diazepam"", ""start_span"": 197, ""end_span"": 205, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 211, ""end_span"": 216, ""type"": ""Chemical/Drug""}]"	train
Experiments in vitro showed that acetylcholine - induced catecholamine release from bovine adrenal medulla is depressed as much as 50% by 0. 3 mM NH4Ac and KCl - induced contractions of guinea - pig ileum were inhibited 20% by 5 mM NH4Ac.	acetylcholine,33,46,Chemical/Drug	catecholamine,57,70,Chemical/Drug	NH4Ac,146,151,Chemical/Drug	KCl,156,159,Chemical/Drug	NH4Ac,232,237,Chemical/Drug	"[{""token"": ""acetylcholine"", ""start_span"": 33, ""end_span"": 46, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 57, ""end_span"": 70, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 146, ""end_span"": 151, ""type"": ""Chemical/Drug""}, {""token"": ""KCl"", ""start_span"": 156, ""end_span"": 159, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Chemical/Drug""}]"	train
Addition of excess calcium reversed the depression in both tissues, but calcium - independent catecholamine release by acetaldehyde was not blocked by NH4Ac.	calcium,19,26,Chemical/Drug	calcium,72,79,Chemical/Drug	catecholamine,94,107,Chemical/Drug	acetaldehyde,119,131,Chemical/Drug	NH4Ac,151,156,Chemical/Drug	"[{""token"": ""calcium"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Chemical/Drug""}, {""token"": ""calcium"", ""start_span"": 72, ""end_span"": 79, ""type"": ""Chemical/Drug""}, {""token"": ""catecholamine"", ""start_span"": 94, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""acetaldehyde"", ""start_span"": 119, ""end_span"": 131, ""type"": ""Chemical/Drug""}, {""token"": ""NH4Ac"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Chemical/Drug""}]"	train
These results suggest that PGs are involved in the mechanism ( s) underlying fluorthyl - and PTZ - induced convulsions, but not picrotoxin -, electroshock -, or bicuculline - induced convulsions.	PGs,27,30,Chemical/Drug	fluorthyl,77,86,Chemical/Drug	PTZ,93,96,Chemical/Drug	picrotoxin,128,138,Chemical/Drug	bicuculline,161,172,Chemical/Drug	"[{""token"": ""PGs"", ""start_span"": 27, ""end_span"": 30, ""type"": ""Chemical/Drug""}, {""token"": ""fluorthyl"", ""start_span"": 77, ""end_span"": 86, ""type"": ""Chemical/Drug""}, {""token"": ""PTZ"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""picrotoxin"", ""start_span"": 128, ""end_span"": 138, ""type"": ""Chemical/Drug""}, {""token"": ""bicuculline"", ""start_span"": 161, ""end_span"": 172, ""type"": ""Chemical/Drug""}]"	train
Serotonin and N - acetyl serotonin which augmented ketamine DOC, did not do so in the absence of the pineal gland, whereas melatonin potentiated the ketamine DOC in both the intact and pinealectomized chick.	Serotonin,0,9,Chemical/Drug	N - acetyl serotonin,14,34,Chemical/Drug	ketamine,51,59,Chemical/Drug	melatonin,123,132,Chemical/Drug	ketamine,149,157,Chemical/Drug	"[{""token"": ""Serotonin"", ""start_span"": 0, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""N - acetyl serotonin"", ""start_span"": 14, ""end_span"": 34, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 51, ""end_span"": 59, ""type"": ""Chemical/Drug""}, {""token"": ""melatonin"", ""start_span"": 123, ""end_span"": 132, ""type"": ""Chemical/Drug""}, {""token"": ""ketamine"", ""start_span"": 149, ""end_span"": 157, ""type"": ""Chemical/Drug""}]"	train
A 31 - year - old man with rheumatoid arthritis, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and gold salts, developed renal papillary necrosis ( RPN) 4 months after institution of naproxen therapy.	sulindac,86,94,Chemical/Drug	fenoprofen calcium,96,114,Chemical/Drug	salicylates,126,137,Chemical/Drug	gold,142,146,Chemical/Drug	naproxen,226,234,Chemical/Drug	"[{""token"": ""sulindac"", ""start_span"": 86, ""end_span"": 94, ""type"": ""Chemical/Drug""}, {""token"": ""fenoprofen calcium"", ""start_span"": 96, ""end_span"": 114, ""type"": ""Chemical/Drug""}, {""token"": ""salicylates"", ""start_span"": 126, ""end_span"": 137, ""type"": ""Chemical/Drug""}, {""token"": ""gold"", ""start_span"": 142, ""end_span"": 146, ""type"": ""Chemical/Drug""}, {""token"": ""naproxen"", ""start_span"": 226, ""end_span"": 234, ""type"": ""Chemical/Drug""}]"	train
The effect of L - dopa was correlated with a decrease in blood and brain ammonia, an increase in brain dopamine, and an increase in renal excretion of ammonia and urea.	L - dopa,14,22,Chemical/Drug	ammonia,73,80,Chemical/Drug	dopamine,103,111,Chemical/Drug	ammonia,151,158,Chemical/Drug	urea,163,167,Chemical/Drug	"[{""token"": ""L - dopa"", ""start_span"": 14, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 73, ""end_span"": 80, ""type"": ""Chemical/Drug""}, {""token"": ""dopamine"", ""start_span"": 103, ""end_span"": 111, ""type"": ""Chemical/Drug""}, {""token"": ""ammonia"", ""start_span"": 151, ""end_span"": 158, ""type"": ""Chemical/Drug""}, {""token"": ""urea"", ""start_span"": 163, ""end_span"": 167, ""type"": ""Chemical/Drug""}]"	train
While AAP caused a 117 - fold elevation of serum transaminase activities in mice kept on a standard laboratory diet, which was significantly exacerbated by ethanol and inhibited by nicotinic acid amide ( NAA), adverse effects were noted in animals fed a diet free of precursors of NAD.	AAP,6,9,Chemical/Drug	ethanol,156,163,Chemical/Drug	nicotinic acid amide,181,201,Chemical/Drug	NAA,204,207,Chemical/Drug	NAD,281,284,Chemical/Drug	"[{""token"": ""AAP"", ""start_span"": 6, ""end_span"": 9, ""type"": ""Chemical/Drug""}, {""token"": ""ethanol"", ""start_span"": 156, ""end_span"": 163, ""type"": ""Chemical/Drug""}, {""token"": ""nicotinic acid amide"", ""start_span"": 181, ""end_span"": 201, ""type"": ""Chemical/Drug""}, {""token"": ""NAA"", ""start_span"": 204, ""end_span"": 207, ""type"": ""Chemical/Drug""}, {""token"": ""NAD"", ""start_span"": 281, ""end_span"": 284, ""type"": ""Chemical/Drug""}]"	train
In addition to its use as a stabilizer / rigidifier of membranes, cholesteryl hemisuccinate, tris salt ( CS) administration has also been shown to protect rats from the hepatotoxic effects of carbon tetrachloride ( CCl4).	cholesteryl hemisuccinate,66,91,Chemical/Drug	tris salt,93,102,Chemical/Drug	CS,105,107,Chemical/Drug	carbon tetrachloride,192,212,Chemical/Drug	CCl4,215,219,Chemical/Drug	"[{""token"": ""cholesteryl hemisuccinate"", ""start_span"": 66, ""end_span"": 91, ""type"": ""Chemical/Drug""}, {""token"": ""tris salt"", ""start_span"": 93, ""end_span"": 102, ""type"": ""Chemical/Drug""}, {""token"": ""CS"", ""start_span"": 105, ""end_span"": 107, ""type"": ""Chemical/Drug""}, {""token"": ""carbon tetrachloride"", ""start_span"": 192, ""end_span"": 212, ""type"": ""Chemical/Drug""}, {""token"": ""CCl4"", ""start_span"": 215, ""end_span"": 219, ""type"": ""Chemical/Drug""}]"	train
The therapeutic use of selective DA D1 receptor agonists such as SKF - 82958 ( 6 - chloro - 7, 8 - dihydroxy - 3 - allyl - 1 - phenyl - 2, 3, 4, 5 - tetrahydro - 1H - 3 - benzaze pine hydrobromide) and A - 77636 ( [ 1R, 3S] 3 - [ 1 ' - admantyl] - 1 - aminomethyl - 3, 4 - dihydro - 5, 6 - dihydroxy - 1H - 2 - benzo pyran hydrochloride) seems limited because of their duration of action, which is too short for SKF - 82958 ( < 1 hr) and too long for A - 77636 ( > 20 hr, leading to behavioral tolerance).	DA,33,35,Chemical/Drug	SKF - 82958,65,76,Chemical/Drug	A - 77636,202,211,Chemical/Drug	SKF - 82958,412,423,Chemical/Drug	A - 77636,451,460,Chemical/Drug	"[{""token"": ""DA"", ""start_span"": 33, ""end_span"": 35, ""type"": ""Chemical/Drug""}, {""token"": ""SKF - 82958"", ""start_span"": 65, ""end_span"": 76, ""type"": ""Chemical/Drug""}, {""token"": ""A - 77636"", ""start_span"": 202, ""end_span"": 211, ""type"": ""Chemical/Drug""}, {""token"": ""SKF - 82958"", ""start_span"": 412, ""end_span"": 423, ""type"": ""Chemical/Drug""}, {""token"": ""A - 77636"", ""start_span"": 451, ""end_span"": 460, ""type"": ""Chemical/Drug""}]"	train
